A systematic review of factors affecting medication adherence among patients with osteoporosis

Summary The aim of this review was to identify factors that influence patients’ adherence to anti-osteoporotic therapy. Factors identified that were associated with poorer medication adherence included polypharmacy, older age, and misconceptions about osteoporosis. Physicians need to be aware of the...

Full description

Saved in:
Bibliographic Details
Published inOsteoporosis international Vol. 29; no. 12; pp. 2623 - 2637
Main Authors Yeam, C. T., Chia, S., Tan, H. C. C., Kwan, Y. H., Fong, W., Seng, J. J. B.
Format Journal Article
LanguageEnglish
Published London Springer London 01.12.2018
Springer Nature B.V
Subjects
Bisphosphonates
Bone Density Conservation Agents - therapeutic use
Calcitonin
Case reports
Delivery of Health Care
Endocrinology
Humans
Medication Adherence
Medicine
Medicine & Public Health
Monoclonal antibodies
Orthopedics
Osteoporosis
Osteoporosis - drug therapy
Parathyroid
Parathyroid hormone
Patient compliance
Patients
Polypharmacy
Progestin
Review Article
Rheumatology
Risk Factors
Selective estrogen receptor modulators
Socioeconomic Factors
Strontium
Systematic review
Medication adherence
Osteoporosis
Anti-osteoporotic therapy
Patient compliance
Bisphosphonates
Online AccessGet full text

Cover

Abstract Summary The aim of this review was to identify factors that influence patients’ adherence to anti-osteoporotic therapy. Factors identified that were associated with poorer medication adherence included polypharmacy, older age, and misconceptions about osteoporosis. Physicians need to be aware of these factors so as to optimize therapeutic outcomes for patients. Introduction To identify factors that influence patients’ adherence to anti-osteoporotic therapy. Methods A systematic review of literature was performed for articles published up till January 2018 using PubMed®, PsychINFO®, Embase®, and CINAHL®. Peer-reviewed articles which examined factors associated with anti-osteoporotic medication adherence were included. Classes of anti-osteoporotic therapy included bisphosphonates, parathyroid hormone-related analogue, denosumab, selective estrogen receptor modulators, estrogen/progestin therapy, calcitonin, and strontium ranelate. Meta-analyses, case reports/series, and other systematic reviews were excluded. Identified factors were classified using the World Health Organization’s five dimensions of medication adherence (condition, patient, therapy, health-system, and socio-economic domains). Results Of 2404 articles reviewed, 124 relevant articles were identified. The prevalence of medication adherence ranged from 12.9 to 95.4%. Twenty-four factors with 139 sub-factors were identified. Bisphosphonates were the most well-studied class of medication ( n  = 59, 48%). Condition-related factors that were associated with poorer medication adherence included polypharmacy, and history of falls was associated with higher medication adherence. Patient-related factors which were associated with poorer medication adherence included older age and misconceptions about osteoporosis while therapy-related factors included higher dosing frequency and medication side effects. Health system-based factors associated with poorer medication adherence included care under different medical specialties and lack of patient education. Socio-economic-related factors associated with poorer medication adherence included current smoker and lack of medical insurance coverage. Conclusion This review identified factors associated with poor medication adherence among osteoporotic patients. To optimize therapeutic outcomes for patients, clinicians need to be aware of the complexity of factors affecting medication adherence.
AbstractList The aim of this review was to identify factors that influence patients' adherence to anti-osteoporotic therapy. Factors identified that were associated with poorer medication adherence included polypharmacy, older age, and misconceptions about osteoporosis. Physicians need to be aware of these factors so as to optimize therapeutic outcomes for patients. To identify factors that influence patients' adherence to anti-osteoporotic therapy. A systematic review of literature was performed for articles published up till January 2018 using PubMed®, PsychINFO®, Embase®, and CINAHL®. Peer-reviewed articles which examined factors associated with anti-osteoporotic medication adherence were included. Classes of anti-osteoporotic therapy included bisphosphonates, parathyroid hormone-related analogue, denosumab, selective estrogen receptor modulators, estrogen/progestin therapy, calcitonin, and strontium ranelate. Meta-analyses, case reports/series, and other systematic reviews were excluded. Identified factors were classified using the World Health Organization's five dimensions of medication adherence (condition, patient, therapy, health-system, and socio-economic domains). Of 2404 articles reviewed, 124 relevant articles were identified. The prevalence of medication adherence ranged from 12.9 to 95.4%. Twenty-four factors with 139 sub-factors were identified. Bisphosphonates were the most well-studied class of medication (n = 59, 48%). Condition-related factors that were associated with poorer medication adherence included polypharmacy, and history of falls was associated with higher medication adherence. Patient-related factors which were associated with poorer medication adherence included older age and misconceptions about osteoporosis while therapy-related factors included higher dosing frequency and medication side effects. Health system-based factors associated with poorer medication adherence included care under different medical specialties and lack of patient education. Socio-economic-related factors associated with poorer medication adherence included current smoker and lack of medical insurance coverage. This review identified factors associated with poor medication adherence among osteoporotic patients. To optimize therapeutic outcomes for patients, clinicians need to be aware of the complexity of factors affecting medication adherence.
The aim of this review was to identify factors that influence patients' adherence to anti-osteoporotic therapy. Factors identified that were associated with poorer medication adherence included polypharmacy, older age, and misconceptions about osteoporosis. Physicians need to be aware of these factors so as to optimize therapeutic outcomes for patients. INTRODUCTIONTo identify factors that influence patients' adherence to anti-osteoporotic therapy. METHODSA systematic review of literature was performed for articles published up till January 2018 using PubMed®, PsychINFO®, Embase®, and CINAHL®. Peer-reviewed articles which examined factors associated with anti-osteoporotic medication adherence were included. Classes of anti-osteoporotic therapy included bisphosphonates, parathyroid hormone-related analogue, denosumab, selective estrogen receptor modulators, estrogen/progestin therapy, calcitonin, and strontium ranelate. Meta-analyses, case reports/series, and other systematic reviews were excluded. Identified factors were classified using the World Health Organization's five dimensions of medication adherence (condition, patient, therapy, health-system, and socio-economic domains). RESULTSOf 2404 articles reviewed, 124 relevant articles were identified. The prevalence of medication adherence ranged from 12.9 to 95.4%. Twenty-four factors with 139 sub-factors were identified. Bisphosphonates were the most well-studied class of medication (n = 59, 48%). Condition-related factors that were associated with poorer medication adherence included polypharmacy, and history of falls was associated with higher medication adherence. Patient-related factors which were associated with poorer medication adherence included older age and misconceptions about osteoporosis while therapy-related factors included higher dosing frequency and medication side effects. Health system-based factors associated with poorer medication adherence included care under different medical specialties and lack of patient education. Socio-economic-related factors associated with poorer medication adherence included current smoker and lack of medical insurance coverage. CONCLUSIONThis review identified factors associated with poor medication adherence among osteoporotic patients. To optimize therapeutic outcomes for patients, clinicians need to be aware of the complexity of factors affecting medication adherence.
Summary The aim of this review was to identify factors that influence patients’ adherence to anti-osteoporotic therapy. Factors identified that were associated with poorer medication adherence included polypharmacy, older age, and misconceptions about osteoporosis. Physicians need to be aware of these factors so as to optimize therapeutic outcomes for patients. Introduction To identify factors that influence patients’ adherence to anti-osteoporotic therapy. Methods A systematic review of literature was performed for articles published up till January 2018 using PubMed®, PsychINFO®, Embase®, and CINAHL®. Peer-reviewed articles which examined factors associated with anti-osteoporotic medication adherence were included. Classes of anti-osteoporotic therapy included bisphosphonates, parathyroid hormone-related analogue, denosumab, selective estrogen receptor modulators, estrogen/progestin therapy, calcitonin, and strontium ranelate. Meta-analyses, case reports/series, and other systematic reviews were excluded. Identified factors were classified using the World Health Organization’s five dimensions of medication adherence (condition, patient, therapy, health-system, and socio-economic domains). Results Of 2404 articles reviewed, 124 relevant articles were identified. The prevalence of medication adherence ranged from 12.9 to 95.4%. Twenty-four factors with 139 sub-factors were identified. Bisphosphonates were the most well-studied class of medication ( n  = 59, 48%). Condition-related factors that were associated with poorer medication adherence included polypharmacy, and history of falls was associated with higher medication adherence. Patient-related factors which were associated with poorer medication adherence included older age and misconceptions about osteoporosis while therapy-related factors included higher dosing frequency and medication side effects. Health system-based factors associated with poorer medication adherence included care under different medical specialties and lack of patient education. Socio-economic-related factors associated with poorer medication adherence included current smoker and lack of medical insurance coverage. Conclusion This review identified factors associated with poor medication adherence among osteoporotic patients. To optimize therapeutic outcomes for patients, clinicians need to be aware of the complexity of factors affecting medication adherence.
SummaryThe aim of this review was to identify factors that influence patients’ adherence to anti-osteoporotic therapy. Factors identified that were associated with poorer medication adherence included polypharmacy, older age, and misconceptions about osteoporosis. Physicians need to be aware of these factors so as to optimize therapeutic outcomes for patients.IntroductionTo identify factors that influence patients’ adherence to anti-osteoporotic therapy.MethodsA systematic review of literature was performed for articles published up till January 2018 using PubMed®, PsychINFO®, Embase®, and CINAHL®. Peer-reviewed articles which examined factors associated with anti-osteoporotic medication adherence were included. Classes of anti-osteoporotic therapy included bisphosphonates, parathyroid hormone-related analogue, denosumab, selective estrogen receptor modulators, estrogen/progestin therapy, calcitonin, and strontium ranelate. Meta-analyses, case reports/series, and other systematic reviews were excluded. Identified factors were classified using the World Health Organization’s five dimensions of medication adherence (condition, patient, therapy, health-system, and socio-economic domains).ResultsOf 2404 articles reviewed, 124 relevant articles were identified. The prevalence of medication adherence ranged from 12.9 to 95.4%. Twenty-four factors with 139 sub-factors were identified. Bisphosphonates were the most well-studied class of medication (n = 59, 48%). Condition-related factors that were associated with poorer medication adherence included polypharmacy, and history of falls was associated with higher medication adherence. Patient-related factors which were associated with poorer medication adherence included older age and misconceptions about osteoporosis while therapy-related factors included higher dosing frequency and medication side effects. Health system-based factors associated with poorer medication adherence included care under different medical specialties and lack of patient education. Socio-economic-related factors associated with poorer medication adherence included current smoker and lack of medical insurance coverage.ConclusionThis review identified factors associated with poor medication adherence among osteoporotic patients. To optimize therapeutic outcomes for patients, clinicians need to be aware of the complexity of factors affecting medication adherence.
Author Tan, H. C. C.
Kwan, Y. H.
Seng, J. J. B.
Chia, S.
Fong, W.
Yeam, C. T.
Author_xml – sequence: 1
  givenname: C. T.
  surname: Yeam
  fullname: Yeam, C. T.
  organization: Duke-NUS Medical School
– sequence: 2
  givenname: S.
  surname: Chia
  fullname: Chia, S.
  organization: Duke-NUS Medical School
– sequence: 3
  givenname: H. C. C.
  surname: Tan
  fullname: Tan, H. C. C.
  organization: Duke-NUS Medical School
– sequence: 4
  givenname: Y. H.
  surname: Kwan
  fullname: Kwan, Y. H.
  organization: Duke-NUS Medical School, Program in Health Services and Systems Research, Duke-NUS Medical School
– sequence: 5
  givenname: W.
  surname: Fong
  fullname: Fong, W.
  organization: Duke-NUS Medical School, Department of Rheumatology and Immunology, Singapore General Hospital, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore
– sequence: 6
  givenname: J. J. B.
  surname: Seng
  fullname: Seng, J. J. B.
  email: benjamin.seng@u.duke.nus.edu
  organization: Duke-NUS Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30417253$$D View this record in MEDLINE/PubMed
BookMark eNp1kMtKAzEUhoNUbKs-gBsJuHEzmts0k2URb1Bwo-DKkMmc2CmdpCZTi29vSr2A4CqQ8_1_Tr4xGvjgAaETSi4oIfIyEUJVVRBaFUKWquB7aEQF5wVTk3KARkRxWShBn4donNKC5IxS8gANORFUspKP0MsUp4_UQ2f61uII7y1scHDYGduHmLBxDmzf-lfcQdPaTAWPTTOHCN4CNl3Io1W-Bt8nvGn7OQ65LqxCDKlNR2jfmWWC46_zED3dXD9e3RWzh9v7q-mssEJM-qLisgLJ6rLirgRR88aBcbUFzmoODSkpnThSUdYIJ2XDhSKNVI5MqOIMGPBDdL7rXcXwtobU665NFpZL4yGsk2aUMyYUUyKjZ3_QRVhHn7fbUlQKWiqVKbqjbP5HiuD0KradiR-aEr2Vr3fydZavt_I1z5nTr-Z1nW39JL5tZ4DtgJRH_hXi79P_t34C2AKRxg
CitedBy_id crossref_primary_10_3390_foods10040720
crossref_primary_10_1007_s00198_023_06693_y
crossref_primary_10_1055_s_0041_1735182
crossref_primary_10_3390_ijms22010053
crossref_primary_10_1007_s00223_019_00607_z
crossref_primary_10_2147_RMHP_S265264
crossref_primary_10_17802_2306_1278_2021_10_4_17_28
crossref_primary_10_26599_NTM_2022_9130003
crossref_primary_10_1007_s00774_021_01216_3
crossref_primary_10_1007_s00402_023_05132_1
crossref_primary_10_1007_s00198_020_05507_9
crossref_primary_10_51847_7bCjkpCKNO
crossref_primary_10_11005_jbm_2024_31_1_13
crossref_primary_10_1093_jbmr_zjae060
crossref_primary_10_1371_journal_pone_0272985
crossref_primary_10_1111_hex_13361
crossref_primary_10_1007_s11657_021_00988_5
crossref_primary_10_1007_s40520_024_02696_9
crossref_primary_10_1007_s11657_021_01012_6
crossref_primary_10_1080_09513590_2019_1689554
crossref_primary_10_1016_j_bone_2020_115838
crossref_primary_10_1002_jcb_28994
crossref_primary_10_1007_s00198_021_06204_x
crossref_primary_10_3389_fbioe_2024_1335955
crossref_primary_10_3390_ijerph18158144
crossref_primary_10_17816_RFD71151
crossref_primary_10_1177_23333928211047024
crossref_primary_10_3390_jcm11175035
crossref_primary_10_1007_s00198_022_06298_x
crossref_primary_10_1007_s40520_022_02100_4
crossref_primary_10_2147_PPA_S376686
crossref_primary_10_1007_s11657_023_01359_y
crossref_primary_10_2147_PPA_S323393
crossref_primary_10_1097_AOG_0000000000004730
crossref_primary_10_1002_acr_24032
crossref_primary_10_7717_peerj_16384
crossref_primary_10_2147_PPA_S426358
crossref_primary_10_1007_s00198_019_05010_w
crossref_primary_10_1007_s11255_020_02452_8
crossref_primary_10_20945_2359_3997000000522
crossref_primary_10_21518_2079_701X_2022_16_21_163_173
crossref_primary_10_1007_s00198_023_06789_5
crossref_primary_10_1007_s00198_023_06845_0
crossref_primary_10_1007_s11657_020_00774_9
crossref_primary_10_3399_bjgp20X713081
crossref_primary_10_1002_jbm4_10498
crossref_primary_10_17116_profmed20192201157
crossref_primary_10_1016_j_cger_2022_05_011
crossref_primary_10_1007_s11657_023_01301_2
crossref_primary_10_1002_jbmr_4627
crossref_primary_10_1007_s00198_022_06350_w
crossref_primary_10_1111_ijcp_13489
crossref_primary_10_2106_JBJS_OA_20_00142
crossref_primary_10_3803_EnM_2023_1663
crossref_primary_10_2196_19089
crossref_primary_10_1007_s11606_021_06648_1
crossref_primary_10_1007_s11657_019_0633_y
crossref_primary_10_1177_1759720X231212747
crossref_primary_10_1002_jbmr_4231
crossref_primary_10_1007_s11657_023_01230_0
crossref_primary_10_2147_PPA_S374685
crossref_primary_10_1007_s00198_024_07014_7
crossref_primary_10_1007_s10067_020_05561_y
crossref_primary_10_1007_s00228_019_02818_7
crossref_primary_10_52888_0514_2515_2021_350_48_54
crossref_primary_10_1186_s12891_020_03760_x
crossref_primary_10_1007_s11657_023_01314_x
crossref_primary_10_2147_PPA_S310613
crossref_primary_10_1007_s00198_020_05312_4
crossref_primary_10_2147_PPA_S362464
crossref_primary_10_3390_jcm12010014
crossref_primary_10_1007_s00198_019_05104_5
crossref_primary_10_2106_JBJS_20_00795
crossref_primary_10_1186_s12889_020_8292_x
crossref_primary_10_1016_j_eprac_2022_06_011
crossref_primary_10_1080_02701367_2020_1788699
crossref_primary_10_1177_20406223221114214
crossref_primary_10_11005_jbm_2022_29_4_205
crossref_primary_10_31478_202011f
crossref_primary_10_1186_s12902_022_01000_y
crossref_primary_10_1097_PRS_0000000000007605
crossref_primary_10_1007_s00198_020_05802_5
crossref_primary_10_2147_PPA_S400039
crossref_primary_10_1007_s00774_023_01411_4
crossref_primary_10_1016_j_biopha_2021_112390
crossref_primary_10_1210_jendso_bvad085
crossref_primary_10_1007_s00198_020_05290_7
crossref_primary_10_1016_j_spinee_2019_10_020
crossref_primary_10_1097_OI9_0000000000000192
crossref_primary_10_2147_PPA_S371162
crossref_primary_10_1007_s11657_020_00809_1
crossref_primary_10_1007_s11657_020_00787_4
crossref_primary_10_1007_s11657_021_00993_8
crossref_primary_10_1186_s12889_023_16387_z
crossref_primary_10_1007_s00774_020_01188_w
crossref_primary_10_1007_s00198_020_05378_0
crossref_primary_10_1007_s11657_023_01318_7
crossref_primary_10_14412_1995_4484_2019_415_420
crossref_primary_10_1007_s00198_022_06658_7
crossref_primary_10_3390_ijerph18084308
crossref_primary_10_1038_s41598_020_65921_1
crossref_primary_10_2147_PPA_S297170
crossref_primary_10_1186_s12877_023_03835_z
crossref_primary_10_1007_s11657_022_01197_4
crossref_primary_10_1186_s13643_023_02181_w
crossref_primary_10_2147_PPA_S397424
crossref_primary_10_1155_2022_6431151
crossref_primary_10_1016_j_bone_2023_116954
crossref_primary_10_2147_PPA_S319084
crossref_primary_10_1080_08870446_2022_2144923
crossref_primary_10_1016_j_bonr_2021_101149
crossref_primary_10_1016_j_archger_2024_105558
crossref_primary_10_1007_s40266_020_00804_8
crossref_primary_10_1007_s00198_020_05409_w
crossref_primary_10_1007_s40520_023_02682_7
crossref_primary_10_1148_radiol_233396
crossref_primary_10_1007_s40273_023_01270_x
Cites_doi 10.1002/acr.21638
10.1359/jbmr.080418
10.1111/dme.12651
10.1186/1471-2474-15-112
10.1007/s00198-008-0618-y
10.18553/jmcp.1998.4.5.488
10.1007/s00198-015-3253-4
10.1155/2013/654218
10.1007/s00198-014-2871-6
10.18553/jmcp.2015.21.9.824
10.1097/gme.0b013e31816be98a
10.1185/030079906x154042
10.2165/00002512-200724070-00007
10.1016/j.pec.2013.06.014
10.1177/1062860607307990
10.1002/jbmr.2269
10.1007/s00198-012-2221-5
10.1016/S0378-5122(97)00076-5
10.1007/s00198-016-3693-5
10.1007/s11657-015-0237-0
10.1007/s00198-011-1850-4
10.1080/03007995.2018.1477747
10.1007/s00198-006-0136-8
10.1080/cmt.6.2.96.103
10.1007/s00198-015-3164-4
10.1007/s00198-014-2810-6
10.1007/s00198-017-4271-1
10.1185/03007990903538409
10.1007/s00198-014-2762-x
10.1007/s00198-011-1635-9
10.1007/s00198-013-2364-z
10.1185/030079905x61875
10.4103/0976-7800.127788
10.1007/s00198-010-1365-4
10.5414/cp202072
10.1007/s11657-015-0231-6
10.1016/j.curtheres.2005.01.003
10.2165/11317070-000000000-00000
10.1007/s12325-016-0360-3
10.1007/s00198-013-2326-5
10.1016/j.maturitas.2008.07.009
10.1016/j.jamda.2015.01.073
10.1007/s00198-015-3084-3
10.1002/acr.21777
10.1185/03007995.2015.1053049
10.1185/03007x226357
10.1007/s00198-006-0172-4
10.3109/13697137.2010.514628
10.1186/s12891-017-1514-4
10.1007/s11657-017-0337-0
10.1007/s00198-009-0930-1
10.1001/archinte.166.11.1209
10.1007/s00198-007-0406-0
10.1007/s00774-007-0768-6
10.1007/s00296-009-0940-5
10.1007/s00198-015-3271-2
10.1016/j.clinthera.2013.05.019
10.1186/1472-6874-10-26
10.1097/MLR.0b013e31818afa1c
10.1007/s00198-010-1297-z
10.18553/jmcp.2015.21.6.499
10.1007/s00198-006-0073-6
10.1007/s00198-009-1141-5
10.1007/s00198-006-0085-2
10.1016/s1726-4901(09)70442-3
10.1007/s00198-010-1381-4
10.1111/j.1742-1241.2006.01059.x
10.1007/s00198-015-3378-5
10.1007/s00391-012-0374-7
10.1016/j.clinthera.2006.10.013
10.1007/s00198-005-0015-8
10.1136/jech.2008.084558
10.1007/s11657-017-0351-2
10.1185/03007990903035604
10.1185/030079906x167615
10.1007/s11657-016-0272-5
10.1592/phco.28.4.437
10.1007/s00198-008-0651-x
10.1007/s00198-009-1134-4
10.1007/s00198-009-1133-5
10.1371/journal.pone.0083552
10.1038/s41598-017-10899-6
10.1185/030079906x112688
10.1097/JPT.0b013e3181ff03b4
10.1016/j.afos.2017.10.002
10.1016/j.bonr.2015.10.006
10.1016/j.japh.2017.05.003
10.1007/s00198-007-0471-4
10.1185/030079908x297358
10.1001/archinte.165.20.2414
10.1007/s00774-006-0735-7
10.1007/s00198-016-3763-8
10.1007/s00198-013-2610-4
10.1258/mi.2009.009029
10.1093/fampra/cmw120
10.1007/s00198-015-3388-3
10.1097/01.smj.0000221637.90495.66
10.1007/s00198-006-0166-2
10.1007/s00774-013-0440-2
10.1007/s00198-015-3038-9
10.1097/gme.0b013e318247e86a
10.1016/S0149-2918(04)90023-9
10.1007/s11657-012-0105-0
10.1007/s11606-011-1704-y
10.1185/030079907x242890
10.1016/j.clinthera.2006.01.002
10.1007/s00198-011-1881-x
10.1007/s00198-008-0795-8
10.1002/pds.2344
10.1016/j.clinthera.2008.04.009
10.1097/gme.0b013e3181fda7e7
10.4065/80.7.856
10.1007/s00198-003-1431-2
10.1530/eje-11-0959
10.3109/13697130903452804
10.1186/1471-2474-14-276
10.1177/1403494810371243
10.1007/s40258-013-0078-1
10.1185/030079907x226069
10.18553/jmcp.2017.23.4.503
10.1007/s00198-006-0179-x
10.1007/s00198-010-1372-5
10.1007/s00198-002-1370-3
10.1007/s00198-006-0171-5
10.1007/PL00004148
10.1080/17843286.2017.1412863
10.1007/s11096-013-9871-z
10.1001/archinte.160.14.2101
10.1007/s00774-013-0424-2
10.1111/j.1547-5069.2003.tb00001.x
ContentType Journal Article
Copyright International Osteoporosis Foundation and National Osteoporosis Foundation 2018
Osteoporosis International is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: International Osteoporosis Foundation and National Osteoporosis Foundation 2018
– notice: Osteoporosis International is a copyright of Springer, (2018). All Rights Reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QP
7RV
7TS
7X7
7XB
88E
8AO
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1007/s00198-018-4759-3
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
ProQuest Nursing & Allied Health Database
Physical Education Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Public Health
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection (Alumni)
Physical Education Index
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

ProQuest Public Health
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1433-2965
EndPage 2637
ExternalDocumentID 10_1007_s00198_018_4759_3
30417253
Genre Journal Article
Review
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
123
199
1N0
1SB
203
28-
29O
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFEXP
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
YLTOR
Z45
Z7S
Z7U
Z7V
Z7W
Z7X
Z81
Z82
Z83
Z87
Z8N
Z8O
Z8P
Z8Q
Z8U
Z8V
Z8W
Z91
ZMTXR
ZOVNA
ZXP
~A9
~EX
~KM
AACDK
AAEOY
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
AJOOF
ALIPV
CGR
CUY
CVF
ECM
EIF
EMB
EMOBN
H13
NPM
SV3
AAYXX
ABQSL
CITATION
7QP
7TS
7XB
8FK
K9.
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c446t-8378e72b583f5e4b3dfeafbce32b3ed05116f0812d4f77d3490d79f061932e2e3
IEDL.DBID AGYKE
ISSN 0937-941X
IngestDate Fri Oct 25 22:42:56 EDT 2024
Thu Oct 10 19:05:59 EDT 2024
Fri Dec 06 02:32:53 EST 2024
Wed Oct 16 00:45:13 EDT 2024
Sat Dec 16 12:02:47 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Medication adherence
Osteoporosis
Anti-osteoporotic therapy
Patient compliance
Bisphosphonates
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c446t-8378e72b583f5e4b3dfeafbce32b3ed05116f0812d4f77d3490d79f061932e2e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Undefined-4
PMID 30417253
PQID 2131741599
PQPubID 33762
PageCount 15
ParticipantIDs proquest_miscellaneous_2132249294
proquest_journals_2131741599
crossref_primary_10_1007_s00198_018_4759_3
pubmed_primary_30417253
springer_journals_10_1007_s00198_018_4759_3
PublicationCentury 2000
PublicationDate 2018-12-01
PublicationDateYYYYMMDD 2018-12-01
PublicationDate_xml – month: 12
  year: 2018
  text: 2018-12-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle With other metabolic bone diseases
PublicationTitle Osteoporosis international
PublicationTitleAbbrev Osteoporos Int
PublicationTitleAlternate Osteoporos Int
PublicationYear 2018
Publisher Springer London
Springer Nature B.V
Publisher_xml – name: Springer London
– name: Springer Nature B.V
References Klop, Welsing, Elders, Overbeek, Souverein, Burden, van Onzenoort, Leufkens, Bijlsma, de Vries (CR70) 2015; 26
Steel, Albertazzi, Howarth, Purdie (CR118) 2003; 6
Netelenbos, Geusens, Ypma, Buijs (CR79) 2011; 22
McHorney, Schousboe, Cline, Weiss (CR7) 2007; 23
Palacios, Sanchez-Borrego, Neyro, Quereda, Vazquez, Perez, Perez (CR21) 2009; 15
Gosch, Jeske, Kammerlander, Roth (CR129) 2012; 45
Roerholt, Eiken, Abrahamsen (CR20) 2009; 20
Park, Park, Koo, Lee, Lee, Kim, Lee (CR61) 2017; 18
Modi, Siris, Yang, Fan, Sajjan (CR32) 2015; 21
Ringe, Moller (CR122) 2009; 30
Hadji, Papaioannou, Gielen, Feudjo Tepie, Zhang, Frieling, Geusens, Makras, Resch, Moller, Kalouche-Khalil, Fahrleitner-Pammer (CR22) 2015; 26
Penning-van Beest, Erkens, Olson, Herings (CR31) 2008; 24
van der Zwaard, van Hout, Hugtenburg, van der Horst, Elders (CR123) 2017; 34
Kyvernitakis, Kostev, Kurth, Albert, Hadji (CR27) 2014; 25
DiMatteo, Lepper, Croghan (CR132) 2000; 160
Liu, Michaud, Nayak, Karpf, Owens, Garber (CR137) 2006; 166
Grenard, Munjas, Adams, Suttorp, Maglione, McGlynn, Gellad (CR133) 2011; 26
Sheehy, Kindundu, Barbeau, LeLorier (CR83) 2009; 20
Tasci, Cintosun, Safer, Naharci, Bozoglu, Aydogdu, Doruk (CR15) 2017; 73
Dugard, Jones, Davie (CR29) 2010; 64
Lo, Pressman, Omar, Ettinger (CR38) 2006; 17
Gold, Safi, Trinh (CR108) 2006; 22
Brankin, Walker, Lynch, Aspray, Lis, Cowell (CR102) 2006; 22
Curtis, Westfall, Allison, Freeman, Saag (CR100) 2006; 17
Fahrleitner-Pammer, Papaioannou, Gielen, Feudjo Tepie, Toffis, Frieling, Geusens, Makras, Boschitsch, Callens, Anastasilakis, Niedhart, Resch, Kalouche-Khalil, Hadji (CR17) 2017; 12
Wade, Satram-Hoang, Stolshek (CR28) 2014; 25
Clark, Gould, Tobias, Horne (CR127) 2016; 27
Penning-van Beest, Goettsch, Erkens, Herings (CR51) 2006; 28
Yun, Curtis, Guo, Kilgore, Muntner, Saag, Matthews, Morrisey, Wright, Becker, Delzell (CR19) 2014; 15
Ideguchi, Ohno, Hattori, Ishigatsubo (CR69) 2007; 18
Brask-Lindemann, Cadarette, Eskildsen, Abrahamsen (CR96) 2011; 22
Ganda, Schaffer, Pearson, Seibel (CR84) 2014; 25
Papaioannou, Khan, Belanger, Bensen, Kendler, Theoret, Amin, Brekke, Erdmann, Walker, Adachi (CR124) 2015; 31
Tandon, Sharma, Mahajan, Mahajan, Khajuria, Gillani (CR49) 2014; 5
Gomes, Costa-Paiva, Farhat, Pedro, Pinto-Neto (CR10) 2011; 18
Yu, Yang, Chiu, Hsu, Chou, Su, Lai, Chen, Chen, Cheng (CR16) 2013; 31
Kishimoto, Maehara (CR106) 2015; 10
Cheng, Durden, Limone, Radbill, Juneau, Spangler, Mirza, Stolshek (CR120) 2015; 21
Johnell, Kanis (CR2) 2006; 17
Mikyas, Agodoa, Yurgin (CR4) 2014; 12
Cheen, Kong, Zhang, Tee, Chandran (CR24) 2012; 23
Bianchi, Duca, Vai, Guglielmi, Viti, Battista, Scillitani, Muscarella, Luisetto, Camozzi, Nuti, Caffarelli, Gonnelli, Albanese, De Tullio, Isaia, D'Amelio, Broggi, Croci (CR135) 2015; 26
Borgstrom, Zethraeus, Johnell, Lidgren, Ponzer, Svensson, Abdon, Ornstein, Lunsjo, Thorngren, Sernbo, Rehnberg, Jonsson (CR5) 2006; 17
Ziller, Wetzel, Kyvernitakis, Seker-Pektas, Hadji (CR30) 2011; 14
Ettinger (CR101) 1998; 4
Downey, Foltz, Boccuzzi, Omar, Kahler (CR105) 2006; 99
Lau, Papaioannou, Dolovich, Adachi, Sawka, Burns, Nair, Pathak (CR110) 2008; 54
Cooper, Drake, Brankin (CR119) 2006; 60
Solomon, Avorn, Katz, Finkelstein, Arnold, Polinski, Brookhart (CR25) 2005; 165
Jones, Petrella, Crilly (CR62) 2008; 35
Ringe, Christodoulakos, Mellstrom, Petto, Nickelsen, Marin, Pavo (CR41) 2007; 23
Confavreux, Canoui-Poitrine, Schott, Ambrosi, Tainturier, Chapurlat (CR76) 2012; 166
Reynolds, Muntner, Cheetham, Harrison, Morisky, Silverman, Gold, Vansomphone, Wei, O'Malley (CR55) 2013; 24
Sanfelix-Genoves, Gil-Guillen, Orozco-Beltran, Giner-Ruiz, Pertusa-Martinez, Reig-Moya, Carratala (CR59) 2009; 26
Zarowitz, Cheng, Allen, O'Shea, Stolshek (CR115) 2015; 16
Curtis, Xi, Westfall, Cheng, Lyles, Saag, Delzell (CR52) 2009; 47
Segal, Tamir, Ish-Shalom (CR74) 2003; 5
Lewiecki, Babbitt, Piziak, Ozturk, Bone (CR97) 2008; 30
Carr, Thompson, Cooper (CR36) 2006; 17
Hansen, Pedersen, Konradsen, Abrahamsen (CR6) 2013; 24
Garcia-Sempere, Hurtado, Sanfelix-Genoves, Rodriguez-Bernal, Gil Orozco, Peiro, Sanfelix-Gimeno (CR46) 2017; 7
Foster, Foley, Meadows, Johnston, Wang, Pohl, Long (CR67) 2011; 22
Ziller, Zimmermann, Kalder, Ziller, Seker-Pektas, Hellmeyer, Hadji (CR88) 2010; 26
Iversen, Vora, Servi, Solomon (CR94) 2011; 34
Blotman, Cortet, Hilliquin, Avouac, Allaert, Pouchain, Gaudin, Cotte, El Hasnaoui (CR99) 2007; 24
Abobului, Berghea, Vlad, Balanescu, Opris, Bojinca, Kosevoi Tichie, Predeteanu, Ionescu (CR39) 2015; 8
Pasion, Sivananthan, Kung, Chen, Chen, Mirasol, Tay, Shah, Khan, Tam, Hall, Thiebaud (CR111) 2007; 25
Weiss, Henderson, McHorney, Cramer (CR53) 2007; 23
Hall, Edmonds, Lou, Cram, Roblin, Saag, Wright, Jones, Wolinsky (CR95) 2017; 57
Forbes, Deshpande, Sorio-Vilela, Kutikova, Duffy, Gouni-Berthold, Hagström (CR128) 2018; 34
Lee, Nho, Ha, Koo (CR82) 2012; 23
Schousboe, Dowd, Davison, Kane (CR64) 2010; 21
Weycker, Macarios, Edelsberg, Oster (CR9) 2006; 17
Tosteson, Do, Wade, Anthony, Downs (CR44) 2010; 21
Goldshtein, Rouach, Shamir-Stein, Yu, Chodick (CR81) 2016; 33
Modi, Sen, Adachi, Adami, Cortet, Cooper, Geusens, Mellström, Weaver, van den Bergh, Keown, Sajjan (CR56) 2017; 29
Richards, Cannon, Hayden, Amdur, Lazaro, Mikuls, Reimold, Caplan, Johnson, Schwab, Cherascu, Kerr (CR66) 2012; 64
Tanaka, Sato, Sugihara, Faries, Nojiri, Graham-Clarke, Flynn, Burge (CR37) 2013; 2013
Kamatari, Koto, Ozawa, Urao, Suzuki, Akasaka, Yanagimoto, Sakota (CR89) 2007; 25
Conti, Piscitelli, Italiano, Parma, Caffetti, Giolli, Di Tanna, Guazzini, Brandi (CR112) 2012; 9
Vytrisalova, Blazkova, Palicka, Vlcek, Cejkova, Hala, Pavelka, Koblihova (CR114) 2008; 60
Karlsson, Lundkvist, Psachoulia, Intorcia, Strom (CR117) 2015; 26
Papaioannou, Ioannidis, Adachi, Sebaldt, Ferko, Puglia, Brown, Tenenhouse, Olszynski, Boulos, Hanley, Josse, Murray, Petrie, Goldsmith (CR35) 2003; 14
Hamilton, McCoy, Taggart (CR109) 2003; 14
Erez, Weller, Vaisman, Kreitler (CR134) 2012; 7
Nielsen, Langdahl, Sorensen, Sorensen, Brixen (CR90) 2010; 38
Cook, Emiliozzi, McCabe (CR11) 2007; 22
Zanchetta, Hakim, Lombas (CR48) 2004; 65
Arden, Earl, Fisher, Cooper, Carruthers, Goater (CR23) 2006; 17
Krass, Schieback, Dhippayom (CR131) 2015; 32
Recker, Gallagher, MacCosbe (CR104) 2005; 80
Turbi, Herrero-Beaumont, Acebes, Torrijos, Grana, Miguelez, Sacristan, Marin (CR116) 2004; 26
Salter, McDaid, Bhattacharya, Holland, Marshall, Howe (CR93) 2014; 9
Hiligsmann, Salas, Hughes, Manias, Gwadry-Sridhar, Linck, Cowell (CR136) 2013; 24
Imaz, Zegarra, Gonzalez-Enriquez, Rubio, Alcazar, Amate (CR13) 2010; 21
Jacob, Dreher, Kostev, Hadji (CR50) 2016; 27
Silverman, Siris, Kendler, Belazi, Brown, Gold, Lewiecki, Papaioannou, Simonelli, Ferreira, Balasubramanian, Dakin, Ho, Siddhanti, Stolshek, Recknor (CR58) 2015; 26
Hui, Adams, Niu, Ettinger, Yi, Chandra, Lo (CR73) 2017; 23
Wu, Wei, Sun, Wu (CR80) 2016; 27
de Castro Gomes, Valadares, Pinto-Neto, Morais, Costa-Paiva (CR47) 2012; 19
Cotte, Fardellone, Mercier, Gaudin, Roux (CR45) 2010; 21
Wright, Looker, Saag, Curtis, Delzell, Randall, Dawson-Hughes (CR1) 2014; 29
Cramer, Lynch, Gaudin, Walker, Cowell (CR54) 2006; 28
van Boven, de Boer, Postma, Vegter (CR78) 2013; 31
Reeve, Wiese (CR130) 2014; 36
Curtis, Westfall, Cheng, Lyles, Saag, Delzell (CR12) 2008; 23
Berecki-Gisolf, Hockey, Dobson (CR86) 2008; 15
Burkhart, Sabate (CR14) 2003; 35
Devold, Furu, Skurtveit, Tverdal, Falch, Sogaard (CR75) 2012; 21
Rossini, Bianchi, Di Munno, Giannini, Minisola, Sinigaglia, Adami (CR26) 2006; 17
Huas, Debiais, Blotman, Cortet, Mercier, Rousseaux, Berger, Gaudin, Cotté (CR87) 2010; 10
Cheng, Yu, Hsu, Chen, Su, Yang (CR34) 2013; 35
Chiu, Kuo, Yu, Su, Cheng (CR60) 2013; 14
Strom, Landfeldt (CR121) 2012; 23
Gold, Trinh, Safi (CR107) 2009; 25
Iwamoto, Miyata, Sato, Takeda, Matsumoto (CR18) 2009; 72
Siris, Fan, Yang, Sajjan, Sen, Modi (CR33) 2016; 4
Thorsteinsson, Vestergaard, Eiken (CR85) 2015; 10
Ideguchi, Ohno, Takase, Ueda, Ishigatsubo (CR68) 2008; 19
Roh, Koh, Noh, Gong, Baek (CR40) 2017; 12
Hansen, Swenson, Baltz, Schuna, Jones, Elliott (CR126) 2008; 19
Modi, Sen, Adachi, Adami, Cortet, Cooper, Geusens, Mellstrom, Weaver, van den Bergh, Nguyen, Sajjan (CR113) 2016; 27
Kertes, Dushenat, Vesterman, Lemberger, Bregman, Friedman (CR98) 2008; 10
Shehadeh-Sheeny, Eilat-Tsanani, Bishara, Baron-Epel (CR125) 2013; 93
Solomon, Brookhart, Tsao, Sundaresan, Andrade, Mazor, Yood (CR43) 2011; 22
Curtis, Yun, Matthews, Saag, Delzell (CR72) 2012; 64
Cramer, Amonkar, Hebborn, Altman (CR8) 2005; 21
Lindsay, Olufade, Bauer, Babrowicz, Hahn (CR92) 2016; 11
Casula, Catapano, Piccinelli, Menditto, Manzoli, De Fendi, Orlando, Flacco, Gambera, Filippi, Tragni (CR77) 2014; 20
Briesacher, Andrade, Fouayzi, Chan (CR63) 2008; 28
Tomkova, Telepkova, Vanuga, Killinger, Sulkova, Celec, Payer (CR103) 2014; 52
Vestergaard, Hermann, Gram, Jensen, Kolthoff, Abrahamsen, Brot, Eiken (CR42) 1997; 28
Wozniak, Johnson, McAlister, Beaupre, Bellerose, Rowe, Majumdar (CR65) 2017; 28
Gold, Martin, Frytak, Amonkar, Cosman (CR71) 2007; 23
Gullberg, Johnell, Kanis (CR3) 1997; 7
Castelo-Branco, Cortes, Ferrer (CR57) 2010; 13
Orimo, Sato, Kimura, Wada, Chen, Yoshida, Crawford (CR91) 2017; 3
JF Boven van (4759_CR78) 2013; 31
A Modi (4759_CR113) 2016; 27
I Tanaka (4759_CR37) 2013; 2013
BA Briesacher (4759_CR63) 2008; 28
CA McHorney (4759_CR7) 2007; 23
TJ Jones (4759_CR62) 2008; 35
H Ideguchi (4759_CR68) 2008; 19
F Blotman (4759_CR99) 2007; 24
JD Ringe (4759_CR41) 2007; 23
K Reynolds (4759_CR55) 2013; 24
I Krass (4759_CR131) 2015; 32
SF Hall (4759_CR95) 2017; 57
MD Iversen (4759_CR94) 2011; 34
F Conti (4759_CR112) 2012; 9
I Goldshtein (4759_CR81) 2016; 33
JR Curtis (4759_CR52) 2009; 47
D Brask-Lindemann (4759_CR96) 2011; 22
NC Wright (4759_CR1) 2014; 29
O Strom (4759_CR121) 2012; 23
SA Steel (4759_CR118) 2003; 6
B Gullberg (4759_CR3) 1997; 7
KE Hansen (4759_CR126) 2008; 19
M Hiligsmann (4759_CR136) 2013; 24
A Papaioannou (4759_CR124) 2015; 31
EG Pasion (4759_CR111) 2007; 25
TT Cheng (4759_CR34) 2013; 35
JH Park (4759_CR61) 2017; 18
YK Lee (4759_CR82) 2012; 23
M Vytrisalova (4759_CR114) 2008; 60
A. Modi (4759_CR56) 2017; 29
DC Gomes (4759_CR10) 2011; 18
DH Solomon (4759_CR25) 2005; 165
FE Cotte (4759_CR45) 2010; 21
Y Mikyas (4759_CR4) 2014; 12
P Vestergaard (4759_CR42) 1997; 28
M Kamatari (4759_CR89) 2007; 25
JC Netelenbos (4759_CR79) 2011; 22
JD Ringe (4759_CR122) 2009; 30
JR Curtis (4759_CR12) 2008; 23
J Sanfelix-Genoves (4759_CR59) 2009; 26
H Liu (4759_CR137) 2006; 166
RR Recker (4759_CR104) 2005; 80
NK Arden (4759_CR23) 2006; 17
MN Dugard (4759_CR29) 2010; 64
X Wu (4759_CR80) 2016; 27
B Hamilton (4759_CR109) 2003; 14
ML Bianchi (4759_CR135) 2015; 26
BR Lindsay (4759_CR92) 2016; 11
BC Zwaard van der (4759_CR123) 2017; 34
FJ Penning-van Beest (4759_CR31) 2008; 24
PF Cook (4759_CR11) 2007; 22
JR Curtis (4759_CR72) 2012; 64
RL Hui (4759_CR73) 2017; 23
FJ Penning-van Beest (4759_CR51) 2006; 28
C Castelo-Branco (4759_CR57) 2010; 13
B Ettinger (4759_CR101) 1998; 4
DS Nielsen (4759_CR90) 2010; 38
O Johnell (4759_CR2) 2006; 17
A Cooper (4759_CR119) 2006; 60
E Reeve (4759_CR130) 2014; 36
L Jacob (4759_CR50) 2016; 27
EM Clark (4759_CR127) 2016; 27
JL Grenard (4759_CR133) 2011; 26
JA Cramer (4759_CR8) 2005; 21
M Abobului (4759_CR39) 2015; 8
SF Yu (4759_CR16) 2013; 31
AN Tosteson (4759_CR44) 2010; 21
HM Devold (4759_CR75) 2012; 21
JR Zanchetta (4759_CR48) 2004; 65
MR DiMatteo (4759_CR132) 2000; 160
S Palacios (4759_CR21) 2009; 15
H Kishimoto (4759_CR106) 2015; 10
A Shehadeh-Sheeny (4759_CR125) 2013; 93
AJ Carr (4759_CR36) 2006; 17
JS Richards (4759_CR66) 2012; 64
Ilker Tasci (4759_CR15) 2017; 73
K Ganda (4759_CR84) 2014; 25
SW Wade (4759_CR28) 2014; 25
CK Chiu (4759_CR60) 2013; 14
H Ideguchi (4759_CR69) 2007; 18
CB Confavreux (4759_CR76) 2012; 166
SL Silverman (4759_CR58) 2015; 26
P Hadji (4759_CR22) 2015; 26
Carol A. Forbes (4759_CR128) 2018; 34
C Salter (4759_CR93) 2014; 9
I Imaz (4759_CR13) 2010; 21
LA Wozniak (4759_CR65) 2017; 28
J Kertes (4759_CR98) 2008; 10
O Sheehy (4759_CR83) 2009; 20
JT Schousboe (4759_CR64) 2010; 21
A Papaioannou (4759_CR35) 2003; 14
C Turbi (4759_CR116) 2004; 26
M Gosch (4759_CR129) 2012; 45
F Borgstrom (4759_CR5) 2006; 17
BJ Zarowitz (4759_CR115) 2015; 16
PV Burkhart (4759_CR14) 2003; 35
DT Gold (4759_CR71) 2007; 23
J Berecki-Gisolf (4759_CR86) 2008; 15
DT Gold (4759_CR107) 2009; 25
A Fahrleitner-Pammer (4759_CR17) 2017; 12
AL Thorsteinsson (4759_CR85) 2015; 10
YH Roh (4759_CR40) 2017; 12
DT Gold (4759_CR108) 2006; 22
E Lau (4759_CR110) 2008; 54
DH Solomon (4759_CR43) 2011; 22
S Tomkova (4759_CR103) 2014; 52
C Klop (4759_CR70) 2015; 26
H Yun (4759_CR19) 2014; 15
A Modi (4759_CR32) 2015; 21
TW Weiss (4759_CR53) 2007; 23
L Karlsson (4759_CR117) 2015; 26
M Casula (4759_CR77) 2014; 20
EM Lewiecki (4759_CR97) 2008; 30
J Iwamoto (4759_CR18) 2009; 72
D Huas (4759_CR87) 2010; 10
E Brankin (4759_CR102) 2006; 22
V Ziller (4759_CR88) 2010; 26
E Segal (4759_CR74) 2003; 5
DA Castro Gomes de (4759_CR47) 2012; 19
A Garcia-Sempere (4759_CR46) 2017; 7
V Ziller (4759_CR30) 2011; 14
JC Lo (4759_CR38) 2006; 17
M Rossini (4759_CR26) 2006; 17
SA Foster (4759_CR67) 2011; 22
HB Erez (4759_CR134) 2012; 7
C Hansen (4759_CR6) 2013; 24
D Weycker (4759_CR9) 2006; 17
I Kyvernitakis (4759_CR27) 2014; 25
JR Curtis (4759_CR100) 2006; 17
ES Siris (4759_CR33) 2016; 4
LI Cheng (4759_CR120) 2015; 21
MH Cheen (4759_CR24) 2012; 23
H Orimo (4759_CR91) 2017; 3
C Roerholt (4759_CR20) 2009; 20
JA Cramer (4759_CR54) 2006; 28
VR Tandon (4759_CR49) 2014; 5
TW Downey (4759_CR105) 2006; 99
References_xml – volume: 64
  start-page: 1054
  issue: 7
  year: 2012
  end-page: 1060
  ident: CR72
  article-title: Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.21638
  contributor:
    fullname: Delzell
– volume: 23
  start-page: 1435
  issue: 9
  year: 2008
  end-page: 1441
  ident: CR12
  article-title: Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.080418
  contributor:
    fullname: Delzell
– volume: 32
  start-page: 725
  issue: 6
  year: 2015
  end-page: 737
  ident: CR131
  article-title: Adherence to diabetes medication: a systematic review
  publication-title: Diabet Med
  doi: 10.1111/dme.12651
  contributor:
    fullname: Dhippayom
– volume: 15
  start-page: 112
  year: 2014
  ident: CR19
  article-title: Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-15-112
  contributor:
    fullname: Delzell
– volume: 19
  start-page: 1777
  issue: 12
  year: 2008
  end-page: 1783
  ident: CR68
  article-title: Outcomes after switching from one bisphosphonate to another in 146 patients at a single university hospital
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-008-0618-y
  contributor:
    fullname: Ishigatsubo
– volume: 4
  start-page: 488
  issue: 5
  year: 1998
  end-page: 492
  ident: CR101
  article-title: Alendronate use among 812 women: prevalence of gastrointestinal complaints, noncompliance with patient instructions, and discontinuation
  publication-title: J Manag Care Pharm
  doi: 10.18553/jmcp.1998.4.5.488
  contributor:
    fullname: Ettinger
– volume: 8
  start-page: 119
  issue: Spec Issue
  year: 2015
  end-page: 123
  ident: CR39
  article-title: Evaluation of adherence to anti-osteoporosis treatment from the socio-economic context
  publication-title: J Med Life
  contributor:
    fullname: Ionescu
– volume: 26
  start-page: 2401
  issue: 10
  year: 2015
  end-page: 2411
  ident: CR117
  article-title: Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3253-4
  contributor:
    fullname: Strom
– volume: 2013
  start-page: 654218
  year: 2013
  ident: CR37
  article-title: Adherence and persistence with once-daily teriparatide in Japan: a retrospective, prescription database, cohort study
  publication-title: J Osteoporos
  doi: 10.1155/2013/654218
  contributor:
    fullname: Burge
– volume: 26
  start-page: 361
  issue: 1
  year: 2015
  end-page: 372
  ident: CR58
  article-title: Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-014-2871-6
  contributor:
    fullname: Recknor
– volume: 21
  start-page: 824
  issue: 9
  year: 2015
  end-page: 833
  ident: CR120
  article-title: Persistance and compliance with osteroporosis therapies among women in a commercially insured population in the United States
  publication-title: J Manag Care Spec Pharm
  doi: 10.18553/jmcp.2015.21.9.824
  contributor:
    fullname: Stolshek
– volume: 15
  start-page: 984
  issue: 5
  year: 2008
  end-page: 990
  ident: CR86
  article-title: Adherence to bisphosphonate treatment by elderly women
  publication-title: Menopause
  doi: 10.1097/gme.0b013e31816be98a
  contributor:
    fullname: Dobson
– volume: 22
  start-page: 2383
  issue: 12
  year: 2006
  end-page: 2391
  ident: CR108
  article-title: Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079906x154042
  contributor:
    fullname: Trinh
– volume: 24
  start-page: 603
  issue: 7
  year: 2007
  end-page: 614
  ident: CR99
  article-title: Characterisation of patients with postmenopausal osteoporosis in French primary healthcare
  publication-title: Drugs Aging
  doi: 10.2165/00002512-200724070-00007
  contributor:
    fullname: El Hasnaoui
– volume: 93
  start-page: 282
  issue: 2
  year: 2013
  end-page: 288
  ident: CR125
  article-title: Knowledge and health literacy are not associated with osteoporotic medication adherence, however income is, in Arab postmenopausal women
  publication-title: Patient Educ Couns
  doi: 10.1016/j.pec.2013.06.014
  contributor:
    fullname: Baron-Epel
– volume: 22
  start-page: 445
  issue: 6
  year: 2007
  end-page: 456
  ident: CR11
  article-title: Telephone counseling to improve osteoporosis treatment adherence: an effectiveness study in community practice settings
  publication-title: Am J Med Qual
  doi: 10.1177/1062860607307990
  contributor:
    fullname: McCabe
– volume: 29
  start-page: 2520
  issue: 11
  year: 2014
  end-page: 2526
  ident: CR1
  article-title: The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.2269
  contributor:
    fullname: Dawson-Hughes
– volume: 10
  start-page: 207
  issue: 3
  year: 2008
  end-page: 213
  ident: CR98
  article-title: Factors contributing to compliance with osteoporosis medication
  publication-title: Isr Med Assoc J
  contributor:
    fullname: Friedman
– volume: 24
  start-page: 2079
  issue: 7
  year: 2013
  end-page: 2097
  ident: CR6
  article-title: Anti-osteoporotic therapy in Denmark--predictors and demographics of poor refill compliance and poor persistence
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-012-2221-5
  contributor:
    fullname: Abrahamsen
– volume: 28
  start-page: 137
  issue: 2
  year: 1997
  end-page: 145
  ident: CR42
  article-title: Improving compliance with hormonal replacement therapy in primary osteoporosis prevention
  publication-title: Maturitas
  doi: 10.1016/S0378-5122(97)00076-5
  contributor:
    fullname: Eiken
– volume: 28
  start-page: 219
  issue: 1
  year: 2017
  end-page: 229
  ident: CR65
  article-title: Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-016-3693-5
  contributor:
    fullname: Majumdar
– volume: 10
  start-page: 35
  year: 2015
  ident: CR85
  article-title: Compliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort study
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-015-0237-0
  contributor:
    fullname: Eiken
– volume: 23
  start-page: 2201
  issue: 8
  year: 2012
  end-page: 2209
  ident: CR121
  article-title: The association between automatic generic substitution and treatment persistence with oral bisphosphonates
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-011-1850-4
  contributor:
    fullname: Landfeldt
– volume: 34
  start-page: 1613
  issue: 9
  year: 2018
  end-page: 1625
  ident: CR128
  article-title: A systematic literature review comparing methods for the measurement of patient persistence and adherence
  publication-title: Current Medical Research and Opinion
  doi: 10.1080/03007995.2018.1477747
  contributor:
    fullname: Hagström
– volume: 17
  start-page: 1268
  issue: 8
  year: 2006
  end-page: 1274
  ident: CR100
  article-title: Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0136-8
  contributor:
    fullname: Saag
– volume: 5
  start-page: 859
  issue: 12
  year: 2003
  end-page: 862
  ident: CR74
  article-title: Compliance of osteoporotic patients with different treatment regimens
  publication-title: Isr Med Assoc J
  contributor:
    fullname: Ish-Shalom
– volume: 6
  start-page: 96
  issue: 2
  year: 2003
  end-page: 103
  ident: CR118
  article-title: Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis
  publication-title: Climacteric
  doi: 10.1080/cmt.6.2.96.103
  contributor:
    fullname: Purdie
– volume: 26
  start-page: 2479
  issue: 10
  year: 2015
  end-page: 2489
  ident: CR22
  article-title: Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3164-4
  contributor:
    fullname: Fahrleitner-Pammer
– volume: 25
  start-page: 2721
  issue: 12
  year: 2014
  end-page: 2728
  ident: CR27
  article-title: Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-014-2810-6
  contributor:
    fullname: Hadji
– volume: 29
  start-page: 329
  issue: 2
  year: 2017
  end-page: 337
  ident: CR56
  article-title: The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study
  publication-title: Osteoporosis International
  doi: 10.1007/s00198-017-4271-1
  contributor:
    fullname: Sajjan
– volume: 26
  start-page: 675
  issue: 3
  year: 2010
  end-page: 681
  ident: CR88
  article-title: Adherence and persistence in patients with severe osteoporosis treated with teriparatide
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007990903538409
  contributor:
    fullname: Hadji
– volume: 25
  start-page: 2279
  issue: 9
  year: 2014
  end-page: 2290
  ident: CR28
  article-title: Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-014-2762-x
  contributor:
    fullname: Stolshek
– volume: 23
  start-page: 1053
  issue: 3
  year: 2012
  end-page: 1060
  ident: CR24
  article-title: Adherence to osteoporosis medications amongst Singaporean patients
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-011-1635-9
  contributor:
    fullname: Chandran
– volume: 24
  start-page: 2907
  issue: 12
  year: 2013
  end-page: 2918
  ident: CR136
  article-title: Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-013-2364-z
  contributor:
    fullname: Cowell
– volume: 54
  start-page: 394
  issue: 3
  year: 2008
  end-page: 402
  ident: CR110
  article-title: Patients’ adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women
  publication-title: Can Fam Physician
  contributor:
    fullname: Pathak
– volume: 21
  start-page: 1453
  issue: 9
  year: 2005
  end-page: 1460
  ident: CR8
  article-title: Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079905x61875
  contributor:
    fullname: Altman
– volume: 5
  start-page: 29
  issue: 1
  year: 2014
  end-page: 33
  ident: CR49
  article-title: First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
  publication-title: J Midlife Health
  doi: 10.4103/0976-7800.127788
  contributor:
    fullname: Gillani
– volume: 22
  start-page: 1493
  issue: 5
  year: 2011
  end-page: 1501
  ident: CR96
  article-title: Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-010-1365-4
  contributor:
    fullname: Abrahamsen
– volume: 52
  start-page: 663
  issue: 8
  year: 2014
  end-page: 668
  ident: CR103
  article-title: Therapeutic adherence to osteoporosis treatment
  publication-title: Int J Clin Pharmacol Ther
  doi: 10.5414/cp202072
  contributor:
    fullname: Payer
– volume: 10
  start-page: 231
  year: 2015
  ident: CR106
  article-title: Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-015-0231-6
  contributor:
    fullname: Maehara
– volume: 65
  start-page: 470
  issue: 6
  year: 2004
  end-page: 480
  ident: CR48
  article-title: Observational study of compliance and continuance rates of raloxifene in the prevention and treatment of osteoporosis
  publication-title: Curr Ther Res Clin Exp
  doi: 10.1016/j.curtheres.2005.01.003
  contributor:
    fullname: Lombas
– volume: 26
  start-page: 861
  issue: 10
  year: 2009
  end-page: 869
  ident: CR59
  article-title: Determinant factors of osteoporosis patients’ reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women
  publication-title: Drugs Aging
  doi: 10.2165/11317070-000000000-00000
  contributor:
    fullname: Carratala
– volume: 33
  start-page: 1374
  issue: 8
  year: 2016
  end-page: 1384
  ident: CR81
  article-title: Role of side effects, physician involvement, and patient perception in non-adherence with oral bisphosphonates
  publication-title: Adv Ther
  doi: 10.1007/s12325-016-0360-3
  contributor:
    fullname: Chodick
– volume: 24
  start-page: 2509
  issue: 9
  year: 2013
  end-page: 2517
  ident: CR55
  article-title: Primary non-adherence to bisphosphonates in an integrated healthcare setting
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-013-2326-5
  contributor:
    fullname: O'Malley
– volume: 60
  start-page: 223
  issue: 3–4
  year: 2008
  end-page: 229
  ident: CR114
  article-title: Self-reported compliance with osteoporosis medication-qualitative aspects and correlates
  publication-title: Maturitas
  doi: 10.1016/j.maturitas.2008.07.009
  contributor:
    fullname: Koblihova
– volume: 16
  start-page: 341
  issue: 4
  year: 2015
  end-page: 348
  ident: CR115
  article-title: Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2015.01.073
  contributor:
    fullname: Stolshek
– volume: 26
  start-page: 1831
  issue: 6
  year: 2015
  end-page: 1840
  ident: CR70
  article-title: Long-term persistence with anti-osteoporosis drugs after fracture
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3084-3
  contributor:
    fullname: de Vries
– volume: 64
  start-page: 1864
  issue: 12
  year: 2012
  end-page: 1870
  ident: CR66
  article-title: Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.21777
  contributor:
    fullname: Kerr
– volume: 31
  start-page: 1391
  issue: 7
  year: 2015
  end-page: 1401
  ident: CR124
  article-title: Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007995.2015.1053049
  contributor:
    fullname: Adachi
– volume: 35
  start-page: 207
  issue: 3
  year: 2003
  ident: CR14
  article-title: Adherence to long-term therapies: evidence for action
  publication-title: J Nurs Scholarsh
  contributor:
    fullname: Sabate
– volume: 23
  start-page: 2677
  issue: 11
  year: 2007
  end-page: 2687
  ident: CR41
  article-title: Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007x226357
  contributor:
    fullname: Pavo
– volume: 17
  start-page: 1726
  issue: 12
  year: 2006
  end-page: 1733
  ident: CR2
  article-title: An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0172-4
  contributor:
    fullname: Kanis
– volume: 14
  start-page: 228
  issue: 2
  year: 2011
  end-page: 235
  ident: CR30
  article-title: Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene
  publication-title: Climacteric
  doi: 10.3109/13697137.2010.514628
  contributor:
    fullname: Hadji
– volume: 18
  start-page: 152
  issue: 1
  year: 2017
  ident: CR61
  article-title: Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/s12891-017-1514-4
  contributor:
    fullname: Lee
– volume: 12
  start-page: 42
  issue: 1
  year: 2017
  ident: CR40
  article-title: Effect of health literacy on adherence to osteoporosis treatment among patients with distal radius fracture
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-017-0337-0
  contributor:
    fullname: Baek
– volume: 21
  start-page: 145
  issue: 1
  year: 2010
  end-page: 155
  ident: CR45
  article-title: Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-0930-1
  contributor:
    fullname: Roux
– volume: 166
  start-page: 1209
  issue: 11
  year: 2006
  end-page: 1217
  ident: CR137
  article-title: The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.166.11.1209
  contributor:
    fullname: Garber
– volume: 18
  start-page: 1421
  issue: 10
  year: 2007
  end-page: 1427
  ident: CR69
  article-title: Persistence with bisphosphonate therapy including treatment courses with multiple sequential bisphosphonates in the real world
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0406-0
  contributor:
    fullname: Ishigatsubo
– volume: 25
  start-page: 302
  issue: 5
  year: 2007
  end-page: 309
  ident: CR89
  article-title: Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-007-0768-6
  contributor:
    fullname: Sakota
– volume: 30
  start-page: 213
  issue: 2
  year: 2009
  end-page: 221
  ident: CR122
  article-title: Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-009-0940-5
  contributor:
    fullname: Moller
– volume: 27
  start-page: 579
  issue: 2
  year: 2016
  end-page: 590
  ident: CR127
  article-title: Natural history, reasons for, and impact of low/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3271-2
  contributor:
    fullname: Horne
– volume: 35
  start-page: 1005
  issue: 7
  year: 2013
  end-page: 1015
  ident: CR34
  article-title: Differences in adherence to osteoporosis regimens: a 2-year analysis of a population treated under specific guidelines
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2013.05.019
  contributor:
    fullname: Yang
– volume: 10
  start-page: 26
  year: 2010
  end-page: 26
  ident: CR87
  article-title: Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment
  publication-title: BMC Womens Health
  doi: 10.1186/1472-6874-10-26
  contributor:
    fullname: Cotté
– volume: 47
  start-page: 334
  issue: 3
  year: 2009
  end-page: 341
  ident: CR52
  article-title: Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis
  publication-title: Med Care
  doi: 10.1097/MLR.0b013e31818afa1c
  contributor:
    fullname: Delzell
– volume: 9
  start-page: 157
  issue: 3
  year: 2012
  end-page: 160
  ident: CR112
  article-title: Adherence to calcium and vitamin D supplementations: results from the ADVICE survey
  publication-title: Clin Cases Miner Bone Metab
  contributor:
    fullname: Brandi
– volume: 22
  start-page: 551
  issue: 2
  year: 2011
  end-page: 557
  ident: CR67
  article-title: Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-010-1297-z
  contributor:
    fullname: Long
– volume: 21
  start-page: 499
  issue: 6
  year: 2015
  end-page: 506
  ident: CR32
  article-title: Association between gastrointestinal events and persistence with osteoporosis therapy: analysis of administrative claims of a U.S. managed care population
  publication-title: J Manag Care Spec Pharm
  doi: 10.18553/jmcp.2015.21.6.499
  contributor:
    fullname: Sajjan
– volume: 17
  start-page: 914
  issue: 6
  year: 2006
  end-page: 921
  ident: CR26
  article-title: Determinants of adherence to osteoporosis treatment in clinical practice
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0073-6
  contributor:
    fullname: Adami
– volume: 21
  start-page: 1899
  issue: 11
  year: 2010
  end-page: 1909
  ident: CR64
  article-title: Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-1141-5
  contributor:
    fullname: Kane
– volume: 17
  start-page: 922
  issue: 6
  year: 2006
  end-page: 928
  ident: CR38
  article-title: Persistence with weekly alendronate therapy among postmenopausal women
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0085-2
  contributor:
    fullname: Ettinger
– volume: 72
  start-page: 619
  issue: 12
  year: 2009
  end-page: 624
  ident: CR18
  article-title: Factors affecting discontinuation of alendronate treatment in postmenopausal Japanese women with osteoporosis
  publication-title: J Chin Med Assoc
  doi: 10.1016/s1726-4901(09)70442-3
  contributor:
    fullname: Matsumoto
– volume: 22
  start-page: 1737
  issue: 6
  year: 2011
  end-page: 1743
  ident: CR43
  article-title: Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-010-1381-4
  contributor:
    fullname: Yood
– volume: 60
  start-page: 896
  issue: 8
  year: 2006
  end-page: 905
  ident: CR119
  article-title: Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study
  publication-title: Int J Clin Pract
  doi: 10.1111/j.1742-1241.2006.01059.x
  contributor:
    fullname: Brankin
– volume: 27
  start-page: 963
  issue: 3
  year: 2016
  end-page: 969
  ident: CR50
  article-title: Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3378-5
  contributor:
    fullname: Hadji
– volume: 45
  start-page: 450
  issue: 6
  year: 2012
  end-page: 454
  ident: CR129
  article-title: Osteoporosis and polypharmacy
  publication-title: Z Gerontol Geriatr
  doi: 10.1007/s00391-012-0374-7
  contributor:
    fullname: Roth
– volume: 28
  start-page: 1686
  issue: 10
  year: 2006
  end-page: 1694
  ident: CR54
  article-title: The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and France
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2006.10.013
  contributor:
    fullname: Cowell
– volume: 17
  start-page: 637
  issue: 5
  year: 2006
  end-page: 650
  ident: CR5
  article-title: Costs and quality of life associated with osteoporosis-related fractures in Sweden
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-005-0015-8
  contributor:
    fullname: Jonsson
– volume: 64
  start-page: 518
  issue: 6
  year: 2010
  end-page: 522
  ident: CR29
  article-title: Uptake of treatment for osteoporosis and compliance after bone density measurement in the community
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech.2008.084558
  contributor:
    fullname: Davie
– volume: 12
  start-page: 58
  issue: 1
  year: 2017
  ident: CR17
  article-title: Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-017-0351-2
  contributor:
    fullname: Hadji
– volume: 25
  start-page: 1831
  issue: 8
  year: 2009
  end-page: 1839
  ident: CR107
  article-title: Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007990903035604
  contributor:
    fullname: Safi
– volume: 23
  start-page: 585
  issue: 3
  year: 2007
  end-page: 594
  ident: CR71
  article-title: A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079906x167615
  contributor:
    fullname: Cosman
– volume: 11
  start-page: 19
  year: 2016
  ident: CR92
  article-title: Patient-reported barriers to osteoporosis therapy
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-016-0272-5
  contributor:
    fullname: Hahn
– volume: 28
  start-page: 437
  issue: 4
  year: 2008
  end-page: 443
  ident: CR63
  article-title: Comparison of drug adherence rates among patients with seven different medical conditions
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.28.4.437
  contributor:
    fullname: Chan
– volume: 20
  start-page: 299
  issue: 2
  year: 2009
  end-page: 307
  ident: CR20
  article-title: Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence
  publication-title: Osteopor Int
  doi: 10.1007/s00198-008-0651-x
  contributor:
    fullname: Abrahamsen
– volume: 21
  start-page: 1943
  issue: 11
  year: 2010
  end-page: 1951
  ident: CR13
  article-title: Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-1134-4
  contributor:
    fullname: Amate
– volume: 21
  start-page: 1769
  issue: 10
  year: 2010
  end-page: 1780
  ident: CR44
  article-title: Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-1133-5
  contributor:
    fullname: Downs
– volume: 9
  start-page: e83552
  issue: 1
  year: 2014
  ident: CR93
  article-title: Abandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0083552
  contributor:
    fullname: Howe
– volume: 7
  start-page: 11784
  issue: 1
  year: 2017
  ident: CR46
  article-title: Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-10899-6
  contributor:
    fullname: Sanfelix-Gimeno
– volume: 22
  start-page: 1249
  issue: 7
  year: 2006
  end-page: 1256
  ident: CR102
  article-title: The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079906x112688
  contributor:
    fullname: Cowell
– volume: 34
  start-page: 72
  issue: 2
  year: 2011
  end-page: 81
  ident: CR94
  article-title: Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers
  publication-title: Journal of geriatric physical therapy (2001)
  doi: 10.1097/JPT.0b013e3181ff03b4
  contributor:
    fullname: Solomon
– volume: 3
  start-page: 174
  issue: 4
  year: 2017
  end-page: 184
  ident: CR91
  article-title: Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: an analysis of patient perceptions
  publication-title: Osteoporos Sarcopenia
  doi: 10.1016/j.afos.2017.10.002
  contributor:
    fullname: Crawford
– volume: 4
  start-page: 5
  year: 2016
  end-page: 10
  ident: CR33
  article-title: Association between gastrointestinal events and compliance with osteoporosis therapy
  publication-title: Bone Rep
  doi: 10.1016/j.bonr.2015.10.006
  contributor:
    fullname: Modi
– volume: 57
  start-page: 503
  issue: 4
  year: 2017
  end-page: 509
  ident: CR95
  article-title: Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy
  publication-title: J Am Pharm Assoc (2003)
  doi: 10.1016/j.japh.2017.05.003
  contributor:
    fullname: Wolinsky
– volume: 20
  start-page: e138
  issue: 5
  year: 2014
  end-page: e145
  ident: CR77
  article-title: Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy
  publication-title: Am J Manag Care
  contributor:
    fullname: Tragni
– volume: 19
  start-page: 349
  issue: 3
  year: 2008
  end-page: 356
  ident: CR126
  article-title: Adherence to alendronate in male veterans
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0471-4
  contributor:
    fullname: Elliott
– volume: 24
  start-page: 1337
  issue: 5
  year: 2008
  end-page: 1344
  ident: CR31
  article-title: Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079908x297358
  contributor:
    fullname: Herings
– volume: 165
  start-page: 2414
  issue: 20
  year: 2005
  end-page: 2419
  ident: CR25
  article-title: Compliance with osteoporosis medications
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.165.20.2414
  contributor:
    fullname: Brookhart
– volume: 25
  start-page: 105
  issue: 2
  year: 2007
  end-page: 113
  ident: CR111
  article-title: Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian women
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-006-0735-7
  contributor:
    fullname: Thiebaud
– volume: 27
  start-page: 3083
  issue: 10
  year: 2016
  end-page: 3090
  ident: CR80
  article-title: Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-016-3763-8
  contributor:
    fullname: Wu
– volume: 25
  start-page: 1345
  issue: 4
  year: 2014
  end-page: 1355
  ident: CR84
  article-title: Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-013-2610-4
  contributor:
    fullname: Seibel
– volume: 15
  start-page: 113
  issue: 3
  year: 2009
  end-page: 119
  ident: CR21
  article-title: Knowledge and compliance from patients with postmenopausal osteoporosis treatment
  publication-title: Menopause Int
  doi: 10.1258/mi.2009.009029
  contributor:
    fullname: Perez
– volume: 34
  start-page: 525
  issue: 5
  year: 2017
  end-page: 531
  ident: CR123
  article-title: Adherence and persistence of patients using oral bone sparing drugs in primary care
  publication-title: Fam Pract
  doi: 10.1093/fampra/cmw120
  contributor:
    fullname: Elders
– volume: 27
  start-page: 1227
  issue: 3
  year: 2016
  end-page: 1238
  ident: CR113
  article-title: Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3388-3
  contributor:
    fullname: Sajjan
– volume: 99
  start-page: 570
  issue: 6
  year: 2006
  end-page: 575
  ident: CR105
  article-title: Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting
  publication-title: South Med J
  doi: 10.1097/01.smj.0000221637.90495.66
  contributor:
    fullname: Kahler
– volume: 17
  start-page: 1638
  issue: 11
  year: 2006
  end-page: 1644
  ident: CR36
  article-title: Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0166-2
  contributor:
    fullname: Cooper
– volume: 31
  start-page: 562
  issue: 5
  year: 2013
  end-page: 570
  ident: CR78
  article-title: Persistence with osteoporosis medication among newly-treated osteoporotic patients
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-013-0440-2
  contributor:
    fullname: Vegter
– volume: 26
  start-page: 1629
  issue: 5
  year: 2015
  end-page: 1638
  ident: CR135
  article-title: Improving adherence to and persistence with oral therapy of osteoporosis
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3038-9
  contributor:
    fullname: Croci
– volume: 19
  start-page: 989
  issue: 9
  year: 2012
  end-page: 994
  ident: CR47
  article-title: Ability to follow drug treatment with calcium and vitamin D in postmenopausal women with reduced bone mass
  publication-title: Menopause
  doi: 10.1097/gme.0b013e318247e86a
  contributor:
    fullname: Costa-Paiva
– volume: 26
  start-page: 245
  issue: 2
  year: 2004
  end-page: 256
  ident: CR116
  article-title: Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study
  publication-title: Clin Ther
  doi: 10.1016/S0149-2918(04)90023-9
  contributor:
    fullname: Marin
– volume: 7
  start-page: 247
  year: 2012
  end-page: 255
  ident: CR134
  article-title: The relationship of depression, anxiety and stress with low bone mineral density in post-menopausal women
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-012-0105-0
  contributor:
    fullname: Kreitler
– volume: 26
  start-page: 1175
  issue: 10
  year: 2011
  end-page: 1182
  ident: CR133
  article-title: Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-011-1704-y
  contributor:
    fullname: Gellad
– volume: 23
  start-page: 3137
  issue: 12
  year: 2007
  end-page: 3152
  ident: CR7
  article-title: The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079907x242890
  contributor:
    fullname: Weiss
– volume: 28
  start-page: 236
  issue: 2
  year: 2006
  end-page: 242
  ident: CR51
  article-title: Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2006.01.002
  contributor:
    fullname: Herings
– volume: 23
  start-page: 2329
  issue: 9
  year: 2012
  end-page: 2333
  ident: CR82
  article-title: Persistence with intravenous zoledronate in elderly patients with osteoporosis
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-011-1881-x
  contributor:
    fullname: Koo
– volume: 20
  start-page: 1369
  issue: 8
  year: 2009
  end-page: 1376
  ident: CR83
  article-title: Differences in persistence among different weekly oral bisphosphonate medications
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-008-0795-8
  contributor:
    fullname: LeLorier
– volume: 21
  start-page: 297
  issue: 3
  year: 2012
  end-page: 304
  ident: CR75
  article-title: Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.2344
  contributor:
    fullname: Sogaard
– volume: 30
  start-page: 605
  issue: 4
  year: 2008
  end-page: 621
  ident: CR97
  article-title: Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluation
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2008.04.009
  contributor:
    fullname: Bone
– volume: 18
  start-page: 531
  issue: 5
  year: 2011
  end-page: 536
  ident: CR10
  article-title: Ability to follow anti-reabsorptive drug treatment in postmenopausal women with reduced bone mass
  publication-title: Menopause
  doi: 10.1097/gme.0b013e3181fda7e7
  contributor:
    fullname: Pinto-Neto
– volume: 35
  start-page: 1865
  issue: 9
  year: 2008
  end-page: 1873
  ident: CR62
  article-title: Determinants of persistence with weekly bisphosphonates in patients with osteoporosis
  publication-title: J Rheumatol
  contributor:
    fullname: Crilly
– volume: 80
  start-page: 856
  issue: 7
  year: 2005
  end-page: 861
  ident: CR104
  article-title: Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women
  publication-title: Mayo Clin Proc
  doi: 10.4065/80.7.856
  contributor:
    fullname: MacCosbe
– volume: 14
  start-page: 808
  issue: 10
  year: 2003
  end-page: 813
  ident: CR35
  article-title: Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-003-1431-2
  contributor:
    fullname: Goldsmith
– volume: 166
  start-page: 735
  issue: 4
  year: 2012
  end-page: 741
  ident: CR76
  article-title: Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje-11-0959
  contributor:
    fullname: Chapurlat
– volume: 13
  start-page: 578
  issue: 6
  year: 2010
  end-page: 584
  ident: CR57
  article-title: Treatment persistence and compliance with a combination of calcium and vitamin D
  publication-title: Climacteric
  doi: 10.3109/13697130903452804
  contributor:
    fullname: Ferrer
– volume: 14
  start-page: 276
  year: 2013
  ident: CR60
  article-title: Adherence to osteoporosis regimens among men and analysis of risk factors of poor compliance: a 2-year analytical review
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-14-276
  contributor:
    fullname: Cheng
– volume: 38
  start-page: 502
  issue: 5
  year: 2010
  end-page: 507
  ident: CR90
  article-title: Persistence to medical treatment of osteoporosis in women at three different clinical settings—a historical cohort study
  publication-title: Scand J Public Health
  doi: 10.1177/1403494810371243
  contributor:
    fullname: Brixen
– volume: 12
  start-page: 267
  issue: 3
  year: 2014
  end-page: 277
  ident: CR4
  article-title: A systematic review of osteoporosis medication adherence and osteoporosis-related fracture costs in men
  publication-title: Appl Health Econ Health Policy
  doi: 10.1007/s40258-013-0078-1
  contributor:
    fullname: Yurgin
– volume: 23
  start-page: 2193
  issue: 9
  year: 2007
  end-page: 2203
  ident: CR53
  article-title: Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079907x226069
  contributor:
    fullname: Cramer
– volume: 23
  start-page: 503
  issue: 4
  year: 2017
  end-page: 512
  ident: CR73
  article-title: Predicting adherence and persistence with oral bisphosphonate therapy in an integrated health care delivery system
  publication-title: J Manag Care Spec Pharm
  doi: 10.18553/jmcp.2017.23.4.503
  contributor:
    fullname: Lo
– volume: 17
  start-page: 1645
  issue: 11
  year: 2006
  end-page: 1652
  ident: CR9
  article-title: Compliance with drug therapy for postmenopausal osteoporosis
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0179-x
  contributor:
    fullname: Oster
– volume: 22
  start-page: 1537
  issue: 5
  year: 2011
  end-page: 1546
  ident: CR79
  article-title: Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in the Netherlands
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-010-1372-5
  contributor:
    fullname: Buijs
– volume: 14
  start-page: 259
  issue: 3
  year: 2003
  end-page: 262
  ident: CR109
  article-title: Tolerability and compliance with risedronate in clinical practice
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-002-1370-3
  contributor:
    fullname: Taggart
– volume: 17
  start-page: 1626
  issue: 11
  year: 2006
  end-page: 1629
  ident: CR23
  article-title: Persistence with teriparatide in patients with osteoporosis: the UK experience
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0171-5
  contributor:
    fullname: Goater
– volume: 7
  start-page: 407
  issue: 5
  year: 1997
  end-page: 413
  ident: CR3
  article-title: World-wide projections for hip fracture
  publication-title: Osteoporos Int
  doi: 10.1007/PL00004148
  contributor:
    fullname: Kanis
– volume: 73
  start-page: 237
  issue: 4
  year: 2017
  end-page: 243
  ident: CR15
  article-title: Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study
  publication-title: Acta Clinica Belgica
  doi: 10.1080/17843286.2017.1412863
  contributor:
    fullname: Doruk
– volume: 36
  start-page: 26
  issue: 1
  year: 2014
  end-page: 29
  ident: CR130
  article-title: Benefits of deprescribing on patients’ adherence to medications
  publication-title: Int J Clin Pharm
  doi: 10.1007/s11096-013-9871-z
  contributor:
    fullname: Wiese
– volume: 160
  start-page: 2101
  issue: 14
  year: 2000
  end-page: 2107
  ident: CR132
  article-title: Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.160.14.2101
  contributor:
    fullname: Croghan
– volume: 31
  start-page: 351
  issue: 3
  year: 2013
  end-page: 359
  ident: CR16
  article-title: Non-adherence to anti-osteoporotic medications in Taiwan: physician specialty makes a difference
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-013-0424-2
  contributor:
    fullname: Cheng
– volume: 26
  start-page: 2479
  issue: 10
  year: 2015
  ident: 4759_CR22
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3164-4
  contributor:
    fullname: P Hadji
– volume: 13
  start-page: 578
  issue: 6
  year: 2010
  ident: 4759_CR57
  publication-title: Climacteric
  doi: 10.3109/13697130903452804
  contributor:
    fullname: C Castelo-Branco
– volume: 24
  start-page: 2509
  issue: 9
  year: 2013
  ident: 4759_CR55
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-013-2326-5
  contributor:
    fullname: K Reynolds
– volume: 5
  start-page: 29
  issue: 1
  year: 2014
  ident: 4759_CR49
  publication-title: J Midlife Health
  doi: 10.4103/0976-7800.127788
  contributor:
    fullname: VR Tandon
– volume: 24
  start-page: 2907
  issue: 12
  year: 2013
  ident: 4759_CR136
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-013-2364-z
  contributor:
    fullname: M Hiligsmann
– volume: 12
  start-page: 58
  issue: 1
  year: 2017
  ident: 4759_CR17
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-017-0351-2
  contributor:
    fullname: A Fahrleitner-Pammer
– volume: 31
  start-page: 562
  issue: 5
  year: 2013
  ident: 4759_CR78
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-013-0440-2
  contributor:
    fullname: JF Boven van
– volume: 18
  start-page: 1421
  issue: 10
  year: 2007
  ident: 4759_CR69
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0406-0
  contributor:
    fullname: H Ideguchi
– volume: 22
  start-page: 1493
  issue: 5
  year: 2011
  ident: 4759_CR96
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-010-1365-4
  contributor:
    fullname: D Brask-Lindemann
– volume: 93
  start-page: 282
  issue: 2
  year: 2013
  ident: 4759_CR125
  publication-title: Patient Educ Couns
  doi: 10.1016/j.pec.2013.06.014
  contributor:
    fullname: A Shehadeh-Sheeny
– volume: 14
  start-page: 259
  issue: 3
  year: 2003
  ident: 4759_CR109
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-002-1370-3
  contributor:
    fullname: B Hamilton
– volume: 25
  start-page: 1831
  issue: 8
  year: 2009
  ident: 4759_CR107
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007990903035604
  contributor:
    fullname: DT Gold
– volume: 9
  start-page: 157
  issue: 3
  year: 2012
  ident: 4759_CR112
  publication-title: Clin Cases Miner Bone Metab
  contributor:
    fullname: F Conti
– volume: 34
  start-page: 72
  issue: 2
  year: 2011
  ident: 4759_CR94
  publication-title: Journal of geriatric physical therapy (2001)
  doi: 10.1097/JPT.0b013e3181ff03b4
  contributor:
    fullname: MD Iversen
– volume: 26
  start-page: 1629
  issue: 5
  year: 2015
  ident: 4759_CR135
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3038-9
  contributor:
    fullname: ML Bianchi
– volume: 9
  start-page: e83552
  issue: 1
  year: 2014
  ident: 4759_CR93
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0083552
  contributor:
    fullname: C Salter
– volume: 34
  start-page: 525
  issue: 5
  year: 2017
  ident: 4759_CR123
  publication-title: Fam Pract
  doi: 10.1093/fampra/cmw120
  contributor:
    fullname: BC Zwaard van der
– volume: 17
  start-page: 922
  issue: 6
  year: 2006
  ident: 4759_CR38
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0085-2
  contributor:
    fullname: JC Lo
– volume: 22
  start-page: 1537
  issue: 5
  year: 2011
  ident: 4759_CR79
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-010-1372-5
  contributor:
    fullname: JC Netelenbos
– volume: 64
  start-page: 1054
  issue: 7
  year: 2012
  ident: 4759_CR72
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.21638
  contributor:
    fullname: JR Curtis
– volume: 26
  start-page: 1175
  issue: 10
  year: 2011
  ident: 4759_CR133
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-011-1704-y
  contributor:
    fullname: JL Grenard
– volume: 23
  start-page: 1053
  issue: 3
  year: 2012
  ident: 4759_CR24
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-011-1635-9
  contributor:
    fullname: MH Cheen
– volume: 24
  start-page: 603
  issue: 7
  year: 2007
  ident: 4759_CR99
  publication-title: Drugs Aging
  doi: 10.2165/00002512-200724070-00007
  contributor:
    fullname: F Blotman
– volume: 35
  start-page: 1865
  issue: 9
  year: 2008
  ident: 4759_CR62
  publication-title: J Rheumatol
  contributor:
    fullname: TJ Jones
– volume: 21
  start-page: 297
  issue: 3
  year: 2012
  ident: 4759_CR75
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.2344
  contributor:
    fullname: HM Devold
– volume: 60
  start-page: 223
  issue: 3–4
  year: 2008
  ident: 4759_CR114
  publication-title: Maturitas
  doi: 10.1016/j.maturitas.2008.07.009
  contributor:
    fullname: M Vytrisalova
– volume: 65
  start-page: 470
  issue: 6
  year: 2004
  ident: 4759_CR48
  publication-title: Curr Ther Res Clin Exp
  doi: 10.1016/j.curtheres.2005.01.003
  contributor:
    fullname: JR Zanchetta
– volume: 21
  start-page: 1453
  issue: 9
  year: 2005
  ident: 4759_CR8
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079905x61875
  contributor:
    fullname: JA Cramer
– volume: 28
  start-page: 219
  issue: 1
  year: 2017
  ident: 4759_CR65
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-016-3693-5
  contributor:
    fullname: LA Wozniak
– volume: 64
  start-page: 1864
  issue: 12
  year: 2012
  ident: 4759_CR66
  publication-title: Arthritis Care Res
  doi: 10.1002/acr.21777
  contributor:
    fullname: JS Richards
– volume: 18
  start-page: 531
  issue: 5
  year: 2011
  ident: 4759_CR10
  publication-title: Menopause
  doi: 10.1097/gme.0b013e3181fda7e7
  contributor:
    fullname: DC Gomes
– volume: 72
  start-page: 619
  issue: 12
  year: 2009
  ident: 4759_CR18
  publication-title: J Chin Med Assoc
  doi: 10.1016/s1726-4901(09)70442-3
  contributor:
    fullname: J Iwamoto
– volume: 17
  start-page: 914
  issue: 6
  year: 2006
  ident: 4759_CR26
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0073-6
  contributor:
    fullname: M Rossini
– volume: 28
  start-page: 236
  issue: 2
  year: 2006
  ident: 4759_CR51
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2006.01.002
  contributor:
    fullname: FJ Penning-van Beest
– volume: 27
  start-page: 3083
  issue: 10
  year: 2016
  ident: 4759_CR80
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-016-3763-8
  contributor:
    fullname: X Wu
– volume: 25
  start-page: 105
  issue: 2
  year: 2007
  ident: 4759_CR111
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-006-0735-7
  contributor:
    fullname: EG Pasion
– volume: 6
  start-page: 96
  issue: 2
  year: 2003
  ident: 4759_CR118
  publication-title: Climacteric
  doi: 10.1080/cmt.6.2.96.103
  contributor:
    fullname: SA Steel
– volume: 19
  start-page: 1777
  issue: 12
  year: 2008
  ident: 4759_CR68
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-008-0618-y
  contributor:
    fullname: H Ideguchi
– volume: 10
  start-page: 231
  year: 2015
  ident: 4759_CR106
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-015-0231-6
  contributor:
    fullname: H Kishimoto
– volume: 29
  start-page: 2520
  issue: 11
  year: 2014
  ident: 4759_CR1
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.2269
  contributor:
    fullname: NC Wright
– volume: 22
  start-page: 445
  issue: 6
  year: 2007
  ident: 4759_CR11
  publication-title: Am J Med Qual
  doi: 10.1177/1062860607307990
  contributor:
    fullname: PF Cook
– volume: 35
  start-page: 1005
  issue: 7
  year: 2013
  ident: 4759_CR34
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2013.05.019
  contributor:
    fullname: TT Cheng
– volume: 14
  start-page: 276
  year: 2013
  ident: 4759_CR60
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-14-276
  contributor:
    fullname: CK Chiu
– volume: 23
  start-page: 585
  issue: 3
  year: 2007
  ident: 4759_CR71
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079906x167615
  contributor:
    fullname: DT Gold
– volume: 26
  start-page: 861
  issue: 10
  year: 2009
  ident: 4759_CR59
  publication-title: Drugs Aging
  doi: 10.2165/11317070-000000000-00000
  contributor:
    fullname: J Sanfelix-Genoves
– volume: 21
  start-page: 1769
  issue: 10
  year: 2010
  ident: 4759_CR44
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-1133-5
  contributor:
    fullname: AN Tosteson
– volume: 73
  start-page: 237
  issue: 4
  year: 2017
  ident: 4759_CR15
  publication-title: Acta Clinica Belgica
  doi: 10.1080/17843286.2017.1412863
  contributor:
    fullname: Ilker Tasci
– volume: 18
  start-page: 152
  issue: 1
  year: 2017
  ident: 4759_CR61
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/s12891-017-1514-4
  contributor:
    fullname: JH Park
– volume: 166
  start-page: 735
  issue: 4
  year: 2012
  ident: 4759_CR76
  publication-title: Eur J Endocrinol
  doi: 10.1530/eje-11-0959
  contributor:
    fullname: CB Confavreux
– volume: 16
  start-page: 341
  issue: 4
  year: 2015
  ident: 4759_CR115
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2015.01.073
  contributor:
    fullname: BJ Zarowitz
– volume: 38
  start-page: 502
  issue: 5
  year: 2010
  ident: 4759_CR90
  publication-title: Scand J Public Health
  doi: 10.1177/1403494810371243
  contributor:
    fullname: DS Nielsen
– volume: 34
  start-page: 1613
  issue: 9
  year: 2018
  ident: 4759_CR128
  publication-title: Current Medical Research and Opinion
  doi: 10.1080/03007995.2018.1477747
  contributor:
    fullname: Carol A. Forbes
– volume: 22
  start-page: 551
  issue: 2
  year: 2011
  ident: 4759_CR67
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-010-1297-z
  contributor:
    fullname: SA Foster
– volume: 4
  start-page: 5
  year: 2016
  ident: 4759_CR33
  publication-title: Bone Rep
  doi: 10.1016/j.bonr.2015.10.006
  contributor:
    fullname: ES Siris
– volume: 12
  start-page: 267
  issue: 3
  year: 2014
  ident: 4759_CR4
  publication-title: Appl Health Econ Health Policy
  doi: 10.1007/s40258-013-0078-1
  contributor:
    fullname: Y Mikyas
– volume: 28
  start-page: 1686
  issue: 10
  year: 2006
  ident: 4759_CR54
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2006.10.013
  contributor:
    fullname: JA Cramer
– volume: 22
  start-page: 1737
  issue: 6
  year: 2011
  ident: 4759_CR43
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-010-1381-4
  contributor:
    fullname: DH Solomon
– volume: 27
  start-page: 963
  issue: 3
  year: 2016
  ident: 4759_CR50
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3378-5
  contributor:
    fullname: L Jacob
– volume: 24
  start-page: 1337
  issue: 5
  year: 2008
  ident: 4759_CR31
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079908x297358
  contributor:
    fullname: FJ Penning-van Beest
– volume: 26
  start-page: 2401
  issue: 10
  year: 2015
  ident: 4759_CR117
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3253-4
  contributor:
    fullname: L Karlsson
– volume: 21
  start-page: 145
  issue: 1
  year: 2010
  ident: 4759_CR45
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-0930-1
  contributor:
    fullname: FE Cotte
– volume: 29
  start-page: 329
  issue: 2
  year: 2017
  ident: 4759_CR56
  publication-title: Osteoporosis International
  doi: 10.1007/s00198-017-4271-1
  contributor:
    fullname: A. Modi
– volume: 17
  start-page: 1626
  issue: 11
  year: 2006
  ident: 4759_CR23
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0171-5
  contributor:
    fullname: NK Arden
– volume: 23
  start-page: 2193
  issue: 9
  year: 2007
  ident: 4759_CR53
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079907x226069
  contributor:
    fullname: TW Weiss
– volume: 35
  start-page: 207
  issue: 3
  year: 2003
  ident: 4759_CR14
  publication-title: J Nurs Scholarsh
  doi: 10.1111/j.1547-5069.2003.tb00001.x
  contributor:
    fullname: PV Burkhart
– volume: 17
  start-page: 1638
  issue: 11
  year: 2006
  ident: 4759_CR36
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0166-2
  contributor:
    fullname: AJ Carr
– volume: 22
  start-page: 1249
  issue: 7
  year: 2006
  ident: 4759_CR102
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079906x112688
  contributor:
    fullname: E Brankin
– volume: 23
  start-page: 1435
  issue: 9
  year: 2008
  ident: 4759_CR12
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.080418
  contributor:
    fullname: JR Curtis
– volume: 21
  start-page: 499
  issue: 6
  year: 2015
  ident: 4759_CR32
  publication-title: J Manag Care Spec Pharm
  doi: 10.18553/jmcp.2015.21.6.499
  contributor:
    fullname: A Modi
– volume: 25
  start-page: 2279
  issue: 9
  year: 2014
  ident: 4759_CR28
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-014-2762-x
  contributor:
    fullname: SW Wade
– volume: 26
  start-page: 1831
  issue: 6
  year: 2015
  ident: 4759_CR70
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3084-3
  contributor:
    fullname: C Klop
– volume: 10
  start-page: 35
  year: 2015
  ident: 4759_CR85
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-015-0237-0
  contributor:
    fullname: AL Thorsteinsson
– volume: 2013
  start-page: 654218
  year: 2013
  ident: 4759_CR37
  publication-title: J Osteoporos
  doi: 10.1155/2013/654218
  contributor:
    fullname: I Tanaka
– volume: 21
  start-page: 1899
  issue: 11
  year: 2010
  ident: 4759_CR64
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-1141-5
  contributor:
    fullname: JT Schousboe
– volume: 30
  start-page: 605
  issue: 4
  year: 2008
  ident: 4759_CR97
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2008.04.009
  contributor:
    fullname: EM Lewiecki
– volume: 21
  start-page: 1943
  issue: 11
  year: 2010
  ident: 4759_CR13
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-1134-4
  contributor:
    fullname: I Imaz
– volume: 165
  start-page: 2414
  issue: 20
  year: 2005
  ident: 4759_CR25
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.165.20.2414
  contributor:
    fullname: DH Solomon
– volume: 26
  start-page: 675
  issue: 3
  year: 2010
  ident: 4759_CR88
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007990903538409
  contributor:
    fullname: V Ziller
– volume: 23
  start-page: 2201
  issue: 8
  year: 2012
  ident: 4759_CR121
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-011-1850-4
  contributor:
    fullname: O Strom
– volume: 11
  start-page: 19
  year: 2016
  ident: 4759_CR92
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-016-0272-5
  contributor:
    fullname: BR Lindsay
– volume: 166
  start-page: 1209
  issue: 11
  year: 2006
  ident: 4759_CR137
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.166.11.1209
  contributor:
    fullname: H Liu
– volume: 10
  start-page: 207
  issue: 3
  year: 2008
  ident: 4759_CR98
  publication-title: Isr Med Assoc J
  contributor:
    fullname: J Kertes
– volume: 17
  start-page: 1726
  issue: 12
  year: 2006
  ident: 4759_CR2
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0172-4
  contributor:
    fullname: O Johnell
– volume: 8
  start-page: 119
  issue: Spec Issue
  year: 2015
  ident: 4759_CR39
  publication-title: J Med Life
  contributor:
    fullname: M Abobului
– volume: 22
  start-page: 2383
  issue: 12
  year: 2006
  ident: 4759_CR108
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079906x154042
  contributor:
    fullname: DT Gold
– volume: 28
  start-page: 137
  issue: 2
  year: 1997
  ident: 4759_CR42
  publication-title: Maturitas
  doi: 10.1016/S0378-5122(97)00076-5
  contributor:
    fullname: P Vestergaard
– volume: 54
  start-page: 394
  issue: 3
  year: 2008
  ident: 4759_CR110
  publication-title: Can Fam Physician
  contributor:
    fullname: E Lau
– volume: 21
  start-page: 824
  issue: 9
  year: 2015
  ident: 4759_CR120
  publication-title: J Manag Care Spec Pharm
  doi: 10.18553/jmcp.2015.21.9.824
  contributor:
    fullname: LI Cheng
– volume: 15
  start-page: 112
  year: 2014
  ident: 4759_CR19
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/1471-2474-15-112
  contributor:
    fullname: H Yun
– volume: 45
  start-page: 450
  issue: 6
  year: 2012
  ident: 4759_CR129
  publication-title: Z Gerontol Geriatr
  doi: 10.1007/s00391-012-0374-7
  contributor:
    fullname: M Gosch
– volume: 32
  start-page: 725
  issue: 6
  year: 2015
  ident: 4759_CR131
  publication-title: Diabet Med
  doi: 10.1111/dme.12651
  contributor:
    fullname: I Krass
– volume: 27
  start-page: 1227
  issue: 3
  year: 2016
  ident: 4759_CR113
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3388-3
  contributor:
    fullname: A Modi
– volume: 19
  start-page: 989
  issue: 9
  year: 2012
  ident: 4759_CR47
  publication-title: Menopause
  doi: 10.1097/gme.0b013e318247e86a
  contributor:
    fullname: DA Castro Gomes de
– volume: 7
  start-page: 407
  issue: 5
  year: 1997
  ident: 4759_CR3
  publication-title: Osteoporos Int
  doi: 10.1007/PL00004148
  contributor:
    fullname: B Gullberg
– volume: 19
  start-page: 349
  issue: 3
  year: 2008
  ident: 4759_CR126
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0471-4
  contributor:
    fullname: KE Hansen
– volume: 160
  start-page: 2101
  issue: 14
  year: 2000
  ident: 4759_CR132
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.160.14.2101
  contributor:
    fullname: MR DiMatteo
– volume: 17
  start-page: 637
  issue: 5
  year: 2006
  ident: 4759_CR5
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-005-0015-8
  contributor:
    fullname: F Borgstrom
– volume: 17
  start-page: 1645
  issue: 11
  year: 2006
  ident: 4759_CR9
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0179-x
  contributor:
    fullname: D Weycker
– volume: 20
  start-page: 299
  issue: 2
  year: 2009
  ident: 4759_CR20
  publication-title: Osteopor Int
  doi: 10.1007/s00198-008-0651-x
  contributor:
    fullname: C Roerholt
– volume: 60
  start-page: 896
  issue: 8
  year: 2006
  ident: 4759_CR119
  publication-title: Int J Clin Pract
  doi: 10.1111/j.1742-1241.2006.01059.x
  contributor:
    fullname: A Cooper
– volume: 25
  start-page: 2721
  issue: 12
  year: 2014
  ident: 4759_CR27
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-014-2810-6
  contributor:
    fullname: I Kyvernitakis
– volume: 20
  start-page: e138
  issue: 5
  year: 2014
  ident: 4759_CR77
  publication-title: Am J Manag Care
  contributor:
    fullname: M Casula
– volume: 17
  start-page: 1268
  issue: 8
  year: 2006
  ident: 4759_CR100
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-006-0136-8
  contributor:
    fullname: JR Curtis
– volume: 25
  start-page: 1345
  issue: 4
  year: 2014
  ident: 4759_CR84
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-013-2610-4
  contributor:
    fullname: K Ganda
– volume: 12
  start-page: 42
  issue: 1
  year: 2017
  ident: 4759_CR40
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-017-0337-0
  contributor:
    fullname: YH Roh
– volume: 47
  start-page: 334
  issue: 3
  year: 2009
  ident: 4759_CR52
  publication-title: Med Care
  doi: 10.1097/MLR.0b013e31818afa1c
  contributor:
    fullname: JR Curtis
– volume: 24
  start-page: 2079
  issue: 7
  year: 2013
  ident: 4759_CR6
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-012-2221-5
  contributor:
    fullname: C Hansen
– volume: 80
  start-page: 856
  issue: 7
  year: 2005
  ident: 4759_CR104
  publication-title: Mayo Clin Proc
  doi: 10.4065/80.7.856
  contributor:
    fullname: RR Recker
– volume: 23
  start-page: 2677
  issue: 11
  year: 2007
  ident: 4759_CR41
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007x226357
  contributor:
    fullname: JD Ringe
– volume: 20
  start-page: 1369
  issue: 8
  year: 2009
  ident: 4759_CR83
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-008-0795-8
  contributor:
    fullname: O Sheehy
– volume: 25
  start-page: 302
  issue: 5
  year: 2007
  ident: 4759_CR89
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-007-0768-6
  contributor:
    fullname: M Kamatari
– volume: 64
  start-page: 518
  issue: 6
  year: 2010
  ident: 4759_CR29
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech.2008.084558
  contributor:
    fullname: MN Dugard
– volume: 7
  start-page: 247
  year: 2012
  ident: 4759_CR134
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-012-0105-0
  contributor:
    fullname: HB Erez
– volume: 14
  start-page: 228
  issue: 2
  year: 2011
  ident: 4759_CR30
  publication-title: Climacteric
  doi: 10.3109/13697137.2010.514628
  contributor:
    fullname: V Ziller
– volume: 5
  start-page: 859
  issue: 12
  year: 2003
  ident: 4759_CR74
  publication-title: Isr Med Assoc J
  contributor:
    fullname: E Segal
– volume: 23
  start-page: 2329
  issue: 9
  year: 2012
  ident: 4759_CR82
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-011-1881-x
  contributor:
    fullname: YK Lee
– volume: 36
  start-page: 26
  issue: 1
  year: 2014
  ident: 4759_CR130
  publication-title: Int J Clin Pharm
  doi: 10.1007/s11096-013-9871-z
  contributor:
    fullname: E Reeve
– volume: 26
  start-page: 361
  issue: 1
  year: 2015
  ident: 4759_CR58
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-014-2871-6
  contributor:
    fullname: SL Silverman
– volume: 26
  start-page: 245
  issue: 2
  year: 2004
  ident: 4759_CR116
  publication-title: Clin Ther
  doi: 10.1016/S0149-2918(04)90023-9
  contributor:
    fullname: C Turbi
– volume: 57
  start-page: 503
  issue: 4
  year: 2017
  ident: 4759_CR95
  publication-title: J Am Pharm Assoc (2003)
  doi: 10.1016/j.japh.2017.05.003
  contributor:
    fullname: SF Hall
– volume: 23
  start-page: 503
  issue: 4
  year: 2017
  ident: 4759_CR73
  publication-title: J Manag Care Spec Pharm
  doi: 10.18553/jmcp.2017.23.4.503
  contributor:
    fullname: RL Hui
– volume: 3
  start-page: 174
  issue: 4
  year: 2017
  ident: 4759_CR91
  publication-title: Osteoporos Sarcopenia
  doi: 10.1016/j.afos.2017.10.002
  contributor:
    fullname: H Orimo
– volume: 52
  start-page: 663
  issue: 8
  year: 2014
  ident: 4759_CR103
  publication-title: Int J Clin Pharmacol Ther
  doi: 10.5414/cp202072
  contributor:
    fullname: S Tomkova
– volume: 99
  start-page: 570
  issue: 6
  year: 2006
  ident: 4759_CR105
  publication-title: South Med J
  doi: 10.1097/01.smj.0000221637.90495.66
  contributor:
    fullname: TW Downey
– volume: 33
  start-page: 1374
  issue: 8
  year: 2016
  ident: 4759_CR81
  publication-title: Adv Ther
  doi: 10.1007/s12325-016-0360-3
  contributor:
    fullname: I Goldshtein
– volume: 10
  start-page: 26
  year: 2010
  ident: 4759_CR87
  publication-title: BMC Womens Health
  doi: 10.1186/1472-6874-10-26
  contributor:
    fullname: D Huas
– volume: 7
  start-page: 11784
  issue: 1
  year: 2017
  ident: 4759_CR46
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-10899-6
  contributor:
    fullname: A Garcia-Sempere
– volume: 23
  start-page: 3137
  issue: 12
  year: 2007
  ident: 4759_CR7
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079907x242890
  contributor:
    fullname: CA McHorney
– volume: 4
  start-page: 488
  issue: 5
  year: 1998
  ident: 4759_CR101
  publication-title: J Manag Care Pharm
  doi: 10.18553/jmcp.1998.4.5.488
  contributor:
    fullname: B Ettinger
– volume: 15
  start-page: 113
  issue: 3
  year: 2009
  ident: 4759_CR21
  publication-title: Menopause Int
  doi: 10.1258/mi.2009.009029
  contributor:
    fullname: S Palacios
– volume: 30
  start-page: 213
  issue: 2
  year: 2009
  ident: 4759_CR122
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-009-0940-5
  contributor:
    fullname: JD Ringe
– volume: 15
  start-page: 984
  issue: 5
  year: 2008
  ident: 4759_CR86
  publication-title: Menopause
  doi: 10.1097/gme.0b013e31816be98a
  contributor:
    fullname: J Berecki-Gisolf
– volume: 28
  start-page: 437
  issue: 4
  year: 2008
  ident: 4759_CR63
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.28.4.437
  contributor:
    fullname: BA Briesacher
– volume: 27
  start-page: 579
  issue: 2
  year: 2016
  ident: 4759_CR127
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-015-3271-2
  contributor:
    fullname: EM Clark
– volume: 31
  start-page: 351
  issue: 3
  year: 2013
  ident: 4759_CR16
  publication-title: J Bone Miner Metab
  doi: 10.1007/s00774-013-0424-2
  contributor:
    fullname: SF Yu
– volume: 14
  start-page: 808
  issue: 10
  year: 2003
  ident: 4759_CR35
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-003-1431-2
  contributor:
    fullname: A Papaioannou
– volume: 31
  start-page: 1391
  issue: 7
  year: 2015
  ident: 4759_CR124
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007995.2015.1053049
  contributor:
    fullname: A Papaioannou
SSID ssj0007997
Score 2.6224954
SecondaryResourceType review_article
Snippet Summary The aim of this review was to identify factors that influence patients’ adherence to anti-osteoporotic therapy. Factors identified that were associated...
The aim of this review was to identify factors that influence patients' adherence to anti-osteoporotic therapy. Factors identified that were associated with...
SummaryThe aim of this review was to identify factors that influence patients’ adherence to anti-osteoporotic therapy. Factors identified that were associated...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 2623
SubjectTerms Bisphosphonates
Bone Density Conservation Agents - therapeutic use
Calcitonin
Case reports
Delivery of Health Care
Endocrinology
Humans
Medication Adherence
Medicine
Medicine & Public Health
Monoclonal antibodies
Orthopedics
Osteoporosis
Osteoporosis - drug therapy
Parathyroid
Parathyroid hormone
Patient compliance
Patients
Polypharmacy
Progestin
Review Article
Rheumatology
Risk Factors
Selective estrogen receptor modulators
Socioeconomic Factors
Strontium
Systematic review
SummonAdditionalLinks – databaseName: ProQuest Public Health Database
  dbid: 8C1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFA86QbyI31anRPCkBNsmbZqTyHAMYZ4c7GRJ2gS9tNNu_78vaboiQ88tSXgvyfvlffweQrdGMG60DAlPE0mYkoIosLNEJ1xwo2RUJLbeefqaTmbsZZ7MvcOt8WmV3Z3oLuqyLqyP_CGOwNKBtRHicfFFbNcoG131LTS20U5kDZ2tFB_1KR5cuOYq8GjnRLBo3kU1Q0ciGtnissj6lhJB6G-7tAE2NwKlzv6MD9C-B474qdX0IdrS1RHanfrQ-DF6f8I9KzNuK1JwbbBvqIOlS9yAobELpzuFYFl-tOV-2DUdwp5ltcHWPYtt_UcN-LxuPpsTNBs_v40mxDdPIAW88JbEEsVrHqskoybRTNESVGJUoWmsqC7hLEapATwQl8xwXlImwpILA-YdEJ2ONT1Fg6qu9DnCjneM0cwAtmHaUtSnnMswUiIsskwWAbrrRJcvWo6MfM2G7OScg5xzK-ecBmjYCTf3x6XJe-UG6Gb9GTa6jV7IStcr909s6Q0FC9BZq5T1bDRkAMQSGPy-01I_-J9Lufh_KZdoL7b7w-WuDNFg-b3SV4BAlurabbMf_-XWfA
  priority: 102
  providerName: ProQuest
Title A systematic review of factors affecting medication adherence among patients with osteoporosis
URI https://link.springer.com/article/10.1007/s00198-018-4759-3
https://www.ncbi.nlm.nih.gov/pubmed/30417253
https://www.proquest.com/docview/2131741599
https://search.proquest.com/docview/2132249294
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB7xkBAXaHm0CxQZqSeQV4ntrOPjgpaiIhCqWGm5ENmJLaqVkorsXvrrO3YeqNr2wCWREstOPB77s2fmG4CvTgnprI6oHCWaCqMVNbjOUptIJZ3RcZ74eOe7-9HNVHyfJbM1YP3RRTkfdhbJMFH3sW4ejHi_K38YlCjK12ETlx6vjJvjb0-3k37-lSqkVMGtuqRKxLPOlvmvSv5ejVYg5op5NKw617tNJGAdyAq9s8l8uFyYYf57lcrxHT_0AXZaEErGzaj5CGu23IOtu9bMvg_PY_LG8Eya6BZSOdIm5yE6OIFgYySY5oNwiS5emtBBEhIYkZaxtSb-qJf4WJIKsX5V_6wPYHo9eby6oW0iBprjbnFBPem8lcwkKXeJFYYXKF5ncsuZ4bZAvY5HDrEFK4STsuBCRYVUDqECokPLLD-EjbIq7WcggcNM8NQhThLW092PpNRRbFSUp6nOB3DeCST71fBtZD2zcuixDHss8z2W8QGcdCLLWtWrMxYjJEJYotQAzvrXqDTeEqJLWy1DGeapEpUYwKdG1H1rPBII6hKs_KKT21vl__2Uo3eVPoZt5gUf3GJOYGPxurRfENwszCmsy5nEa3oVn7YjG--Xk_uHH_h0ysZ_AB12828
link.rule.ids 314,780,784,12056,12223,21388,27924,27925,31719,31720,33266,33267,33744,33745,41081,41523,42150,42592,43310,43579,43805,52111,52234,73745,74014,74302
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9swED6NIgEvaGMDyo_Nk_YEskhiu66fUIdA3WirCbVSnxbZia3tpQFS_n_OjtMKIXhO5Fjf2b4vd77vAH44xaWzOqGyJzTlRitq0M9SK6SSzui0EL7eeTzpDWf891zMY8Ctjtcq2zMxHNRlVfgY-UWWoqdDb6PU5f0D9V2jfHY1ttDYgE2vnC46sPnzevLnbnUWSxXaq-Bvu6SKp_M2r5kEGdHUl5elProkFGUvPdMruvkqVRo80M1H2I3UkQwaW3-CD3axB1vjmBz_DH8HZK3LTJqaFFI5ElvqEB2ubuDQJCTUg0mILv81BX8ktB0iUWe1Jj5AS3wFSIUMvar_119gdnM9vRrS2D6BFviPt6ReKt7KzIg-c8Jyw0o0ijOFZZlhtsTdmPYcMoKs5E7KknGVlFI5dPDI6Wxm2T50FtXCHgIJymOIsEN2w62HuielTlKjkqLf10UXzlro8vtGJSNf6SEHnHPEOfc456wLJy24edwwdb42bxe-rx7jUvf5C72w1VN4J_MCh4p34aAxyuprLOFIxQQOft5aaT34m1M5en8q32B7OB2P8tGvye0x7GR-rYSbLCfQWT4-2VPkI0vzNS66Z0Ju2wo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB50BfEivl2fETwpwbZJN5uT-Fp8LiIKe7IkbYJetqtd_7-TNN1FRM8tSZiZZL5kZr4BOLSSC2tUREUnVZRrJalGP0tNKqSwWsV56uqdH_qd6xd-O0gHIf-pCmmVzZnoD-qizN0b-UkSo6dDbyPliQ1pEY-XvdPRB3UdpFykNbTTmIU59IpR0oK586v-49PkXBbSt1rBK7ygkseDJsYZeUrR2JWaxe6lKZWU_fRSv6Dnr7Cp90a9JVgMMJKc1XpfhhkzXIH5hxAoX4XXMzLlaCZ1fQopLQntdYjyaRw4NPHBda8eooq3uviP-BZEJHCuVsQ91hJXDVIiWi-r92oNXnpXzxfXNLRSoDne98bU0cYbkei0y2xquGYFKsjq3LBEM1Pgzow7FtFBUnArRMG4jAohLTp7xHcmMWwdWsNyaDaBeBYyzroWkQ43jrC-I4SKYi2jvNtVeRuOGtFlo5oxI5twI3s5ZyjnzMk5Y23YaYSbhc1TZVNVt-Fg8hnN3sUy1NCUX_6fxJEdSt6GjVopk9lYxBGWpTj4caOl6eB_LmXr_6XswzzaW3Z_07_bhoXEmYpPatmB1vjzy-wiNBnrvWBz34-N3zc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+systematic+review+of+factors+affecting+medication+adherence+among+patients+with+osteoporosis&rft.jtitle=Osteoporosis+international&rft.au=Yeam%2C+C.+T.&rft.au=Chia%2C+S.&rft.au=Tan%2C+H.+C.+C.&rft.au=Kwan%2C+Y.+H.&rft.date=2018-12-01&rft.pub=Springer+London&rft.issn=0937-941X&rft.eissn=1433-2965&rft.volume=29&rft.issue=12&rft.spage=2623&rft.epage=2637&rft_id=info:doi/10.1007%2Fs00198-018-4759-3&rft.externalDocID=10_1007_s00198_018_4759_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0937-941X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0937-941X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0937-941X&client=summon